JPH10507764A - ブラジキニン拮抗剤としての、ピリドピリミドン類、キノリン類および縮合n−複素環類 - Google Patents
ブラジキニン拮抗剤としての、ピリドピリミドン類、キノリン類および縮合n−複素環類Info
- Publication number
- JPH10507764A JPH10507764A JP8514166A JP51416696A JPH10507764A JP H10507764 A JPH10507764 A JP H10507764A JP 8514166 A JP8514166 A JP 8514166A JP 51416696 A JP51416696 A JP 51416696A JP H10507764 A JPH10507764 A JP H10507764A
- Authority
- JP
- Japan
- Prior art keywords
- group
- nmr
- alkyl
- amino
- cdcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IAAQUOVTPAMQCR-UHFFFAOYSA-N 1h-pyrido[3,2-d]pyrimidin-2-one Chemical class C1=CC=C2NC(=O)N=CC2=N1 IAAQUOVTPAMQCR-UHFFFAOYSA-N 0.000 title abstract description 3
- 229940111121 antirheumatic drug quinolines Drugs 0.000 title abstract description 3
- 239000003152 bradykinin antagonist Substances 0.000 title description 6
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 claims abstract description 179
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 129
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 119
- 239000001257 hydrogen Substances 0.000 claims abstract description 47
- 150000003839 salts Chemical class 0.000 claims abstract description 47
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 38
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 32
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 29
- 150000002367 halogens Chemical class 0.000 claims abstract description 28
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 14
- 201000010099 disease Diseases 0.000 claims abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 8
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 8
- 101800004538 Bradykinin Proteins 0.000 claims abstract description 7
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims abstract description 7
- 102100035792 Kininogen-1 Human genes 0.000 claims abstract description 7
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims abstract description 7
- 241001465754 Metazoa Species 0.000 claims abstract description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 3
- -1 nitro, amino Chemical group 0.000 claims description 285
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 162
- 150000001875 compounds Chemical class 0.000 claims description 106
- 125000003545 alkoxy group Chemical group 0.000 claims description 91
- 125000000623 heterocyclic group Chemical group 0.000 claims description 62
- 125000002252 acyl group Chemical group 0.000 claims description 50
- 125000001424 substituent group Chemical group 0.000 claims description 44
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 34
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 125000003282 alkyl amino group Chemical group 0.000 claims description 31
- 125000004442 acylamino group Chemical group 0.000 claims description 25
- 125000003342 alkenyl group Chemical group 0.000 claims description 23
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 17
- 125000001589 carboacyl group Chemical group 0.000 claims description 12
- 125000003118 aryl group Chemical group 0.000 claims description 11
- 125000004076 pyridyl group Chemical group 0.000 claims description 11
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 9
- 241001024304 Mino Species 0.000 claims description 8
- 125000005110 aryl thio group Chemical group 0.000 claims description 8
- 125000004149 thio group Chemical group *S* 0.000 claims description 8
- 125000006323 alkenyl amino group Chemical group 0.000 claims description 7
- 125000004104 aryloxy group Chemical group 0.000 claims description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
- 125000004193 piperazinyl group Chemical group 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 7
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 6
- 125000004450 alkenylene group Chemical group 0.000 claims description 6
- 125000000539 amino acid group Chemical group 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- 125000001769 aryl amino group Chemical group 0.000 claims description 6
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims description 6
- 125000004999 nitroaryl group Chemical group 0.000 claims description 6
- 125000004423 acyloxy group Chemical group 0.000 claims description 4
- 125000003435 aroyl group Chemical group 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 125000001041 indolyl group Chemical group 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 5
- 125000001475 halogen functional group Chemical group 0.000 claims 4
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims 2
- 239000004727 Noryl Substances 0.000 claims 1
- 229920001207 Noryl Polymers 0.000 claims 1
- 125000005281 alkyl ureido group Chemical group 0.000 claims 1
- 125000006383 alkylpyridyl group Chemical group 0.000 claims 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000006501 nitrophenyl group Chemical group 0.000 claims 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000005493 quinolyl group Chemical group 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 7
- 150000003248 quinolines Chemical class 0.000 abstract description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 323
- 239000000203 mixture Substances 0.000 description 246
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 180
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 166
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 161
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 158
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 132
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 120
- 239000000243 solution Substances 0.000 description 104
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 86
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 80
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 63
- 235000019341 magnesium sulphate Nutrition 0.000 description 63
- 239000012044 organic layer Substances 0.000 description 63
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 61
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 56
- 239000011541 reaction mixture Substances 0.000 description 50
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 44
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 43
- 239000000843 powder Substances 0.000 description 42
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 40
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 39
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 39
- 238000001816 cooling Methods 0.000 description 36
- 239000012267 brine Substances 0.000 description 35
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 35
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 33
- 239000002904 solvent Substances 0.000 description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 26
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 26
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- 239000003921 oil Substances 0.000 description 24
- 238000001035 drying Methods 0.000 description 23
- 239000002244 precipitate Substances 0.000 description 23
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 22
- 239000007787 solid Substances 0.000 description 22
- 238000003756 stirring Methods 0.000 description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 21
- 239000012299 nitrogen atmosphere Substances 0.000 description 21
- 239000000725 suspension Substances 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 19
- 239000002253 acid Substances 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 18
- 238000001914 filtration Methods 0.000 description 18
- 239000005457 ice water Substances 0.000 description 18
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 17
- 238000012746 preparative thin layer chromatography Methods 0.000 description 16
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 16
- 239000011780 sodium chloride Substances 0.000 description 15
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 15
- 229920002554 vinyl polymer Polymers 0.000 description 15
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 14
- 238000000746 purification Methods 0.000 description 14
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical compound C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 239000013078 crystal Substances 0.000 description 12
- 238000003818 flash chromatography Methods 0.000 description 12
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 11
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 11
- 229910000027 potassium carbonate Inorganic materials 0.000 description 11
- 235000011181 potassium carbonates Nutrition 0.000 description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 10
- 125000004043 oxo group Chemical group O=* 0.000 description 10
- 235000011121 sodium hydroxide Nutrition 0.000 description 10
- 238000000967 suction filtration Methods 0.000 description 10
- BVZOKIGKGBZTOU-UHFFFAOYSA-N 4-chloro-2-methylquinolin-8-ol Chemical compound C1=CC=C(O)C2=NC(C)=CC(Cl)=C21 BVZOKIGKGBZTOU-UHFFFAOYSA-N 0.000 description 9
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- 239000012298 atmosphere Substances 0.000 description 9
- 238000004587 chromatography analysis Methods 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 125000004433 nitrogen atom Chemical group N* 0.000 description 9
- 229920006395 saturated elastomer Polymers 0.000 description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 8
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 8
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- 239000012312 sodium hydride Substances 0.000 description 8
- 229910000104 sodium hydride Inorganic materials 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 7
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 6
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical class C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 6
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 6
- 125000004430 oxygen atom Chemical group O* 0.000 description 6
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 6
- 125000004434 sulfur atom Chemical group 0.000 description 6
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 5
- HAIBKCNQUDXDHR-UHFFFAOYSA-N 2-amino-n-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-n-methylacetamide Chemical compound NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl HAIBKCNQUDXDHR-UHFFFAOYSA-N 0.000 description 5
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 5
- 239000004471 Glycine Substances 0.000 description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 5
- 239000004202 carbamide Substances 0.000 description 5
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 5
- 229930016911 cinnamic acid Natural products 0.000 description 5
- 235000013985 cinnamic acid Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 125000005843 halogen group Chemical group 0.000 description 5
- 150000002391 heterocyclic compounds Chemical class 0.000 description 5
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 5
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 5
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- LBEPNLIADKHBQQ-HWKANZROSA-N (e)-3-(6-acetamidopyridin-3-yl)prop-2-enoic acid Chemical compound CC(=O)NC1=CC=C(\C=C\C(O)=O)C=N1 LBEPNLIADKHBQQ-HWKANZROSA-N 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 4
- NBYLBWHHTUWMER-UHFFFAOYSA-N 2-Methylquinolin-8-ol Chemical compound C1=CC=C(O)C2=NC(C)=CC=C21 NBYLBWHHTUWMER-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- MBAGYWDANJNYCS-UHFFFAOYSA-N 2-[(2-bromoacetyl)amino]-n-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-n-methylacetamide Chemical compound BrCC(=O)NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl MBAGYWDANJNYCS-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 4
- 235000019445 benzyl alcohol Nutrition 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- XHFGWHUWQXTGAT-UHFFFAOYSA-N dimethylamine hydrochloride Natural products CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 4
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 4
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical group C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 description 4
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 4
- VFQXVTODMYMSMJ-UHFFFAOYSA-N isonicotinamide Chemical compound NC(=O)C1=CC=NC=C1 VFQXVTODMYMSMJ-UHFFFAOYSA-N 0.000 description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 4
- IBWKCPDCFMRCQJ-UHFFFAOYSA-N (2,6-dimethyl-3-nitrophenyl)methanol Chemical compound CC1=CC=C([N+]([O-])=O)C(C)=C1CO IBWKCPDCFMRCQJ-UHFFFAOYSA-N 0.000 description 3
- UXFZNPGAWHMSRK-UHFFFAOYSA-N 2,4-dimethylquinolin-8-ol Chemical compound C1=CC=C(O)C2=NC(C)=CC(C)=C21 UXFZNPGAWHMSRK-UHFFFAOYSA-N 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- GPRWPUJJVQMKAP-UHFFFAOYSA-N 2-[[[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-methylcarbamoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl GPRWPUJJVQMKAP-UHFFFAOYSA-N 0.000 description 3
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 3
- AZYVWAARJGPHGE-UHFFFAOYSA-N 2-methyl-8-phenylmethoxy-1h-quinolin-4-one Chemical compound C12=NC(C)=CC(O)=C2C=CC=C1OCC1=CC=CC=C1 AZYVWAARJGPHGE-UHFFFAOYSA-N 0.000 description 3
- 125000006479 2-pyridyl methyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- UYRCOTSOPWOSJK-JXTBTVDRSA-N bradykinin antagonist Chemical compound C1C2=CC=CC=C2CC1[C@@H](NC(=O)C(CO)NC(=O)C(NC(=O)CNC(=O)[C@H]1N(C[C@H](O)C1)C(=O)C1N(CCC1)C(=O)C(CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=N)CCCCCCC(=N)N[C@H](CCCNC(N)=N)C(=O)NC(CCCNC(N)=N)C(=O)N1C(CCC1)C(=O)N1[C@@H](C[C@@H](O)C1)C(=O)NCC(=O)NC(C1CC2=CC=CC=C2C1)C(=O)NC(CO)C(=O)N[C@H](C1CC2=CC=CC=C2C1)C(=O)N1C2CCCCC2CC1C(=O)NC(CCCNC(N)=N)C(O)=O)C1CC2=CC=CC=C2C1)C(=O)N1C2CCCCC2CC1C(=O)NC(CCCNC(=N)N)C(O)=O UYRCOTSOPWOSJK-JXTBTVDRSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 229940032296 ferric chloride Drugs 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 3
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 239000000052 vinegar Substances 0.000 description 3
- 235000021419 vinegar Nutrition 0.000 description 3
- SOHAVULMGIITDH-ZXPSTKSJSA-N (1S,9R,14E)-14-(1H-imidazol-5-ylmethylidene)-2,11-dimethoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione Chemical compound C([C@]1(C2=CC=CC=C2N([C@@]21NC1=O)OC)C(C)(C)C=C)=C(OC)C(=O)N2\C1=C\C1=CNC=N1 SOHAVULMGIITDH-ZXPSTKSJSA-N 0.000 description 2
- RERIKHVPXKEGRT-UHFFFAOYSA-N (2,4-dichlorophenoxy)-tri(propan-2-yl)silane Chemical compound CC(C)[Si](C(C)C)(C(C)C)OC1=CC=C(Cl)C=C1Cl RERIKHVPXKEGRT-UHFFFAOYSA-N 0.000 description 2
- UWLFQMMIUUTMSD-UHFFFAOYSA-N (2-methyl-8-phenylmethoxyquinolin-4-yl)methanol Chemical compound C12=NC(C)=CC(CO)=C2C=CC=C1OCC1=CC=CC=C1 UWLFQMMIUUTMSD-UHFFFAOYSA-N 0.000 description 2
- DPBKEHKMLPTJFE-QPJJXVBHSA-N (e)-3-[4-(methylcarbamoyl)phenyl]prop-2-enoic acid Chemical compound CNC(=O)C1=CC=C(\C=C\C(O)=O)C=C1 DPBKEHKMLPTJFE-QPJJXVBHSA-N 0.000 description 2
- ZTKJRFRPZXHQKQ-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinolin-6-ylmethanol Chemical compound N1CCCC2=CC(CO)=CC=C21 ZTKJRFRPZXHQKQ-UHFFFAOYSA-N 0.000 description 2
- FYGHSUNMUKGBRK-UHFFFAOYSA-N 1,2,3-trimethylbenzene Chemical compound CC1=CC=CC(C)=C1C FYGHSUNMUKGBRK-UHFFFAOYSA-N 0.000 description 2
- IRFSXVIRXMYULF-UHFFFAOYSA-N 1,2-dihydroquinoline Chemical compound C1=CC=C2C=CCNC2=C1 IRFSXVIRXMYULF-UHFFFAOYSA-N 0.000 description 2
- ADZUEEUKBYCSEY-UHFFFAOYSA-N 1h-indole-5-carbaldehyde Chemical compound O=CC1=CC=C2NC=CC2=C1 ADZUEEUKBYCSEY-UHFFFAOYSA-N 0.000 description 2
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 2
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 2
- CBIFBOXYPOLRFM-UHFFFAOYSA-N 2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]aniline Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC1=C(Cl)C=CC(N)=C1Cl CBIFBOXYPOLRFM-UHFFFAOYSA-N 0.000 description 2
- RXEFTLRUDVRIPG-UHFFFAOYSA-N 2-(chloromethyl)-1,3-dimethyl-4-nitrobenzene Chemical compound CC1=CC=C([N+]([O-])=O)C(C)=C1CCl RXEFTLRUDVRIPG-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- NDYLYLFABOWEKJ-UHFFFAOYSA-N 2-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenoxy]ethanamine Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC1=C(Cl)C=CC(OCCN)=C1Cl NDYLYLFABOWEKJ-UHFFFAOYSA-N 0.000 description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- SBDWJVPHAGVHHV-UHFFFAOYSA-N 2-methyl-4-morpholin-4-ylquinolin-8-ol Chemical compound C=12C=CC=C(O)C2=NC(C)=CC=1N1CCOCC1 SBDWJVPHAGVHHV-UHFFFAOYSA-N 0.000 description 2
- GJOJHVOXBFIZAG-UHFFFAOYSA-N 2-methyl-8-phenylmethoxyquinoline-4-carbaldehyde Chemical compound C12=NC(C)=CC(C=O)=C2C=CC=C1OCC1=CC=CC=C1 GJOJHVOXBFIZAG-UHFFFAOYSA-N 0.000 description 2
- SWUXODVQEBCDOY-UHFFFAOYSA-N 2-methyl-8-phenylmethoxyquinoline-4-carboxylic acid Chemical compound C12=NC(C)=CC(C(O)=O)=C2C=CC=C1OCC1=CC=CC=C1 SWUXODVQEBCDOY-UHFFFAOYSA-N 0.000 description 2
- BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical compound CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 2
- PREDSQPDUMMLOO-UHFFFAOYSA-N 2-methylpyridine-3-carbonyl chloride;hydrochloride Chemical compound Cl.CC1=NC=CC=C1C(Cl)=O PREDSQPDUMMLOO-UHFFFAOYSA-N 0.000 description 2
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- QSCZTRRXUFFZAI-UHFFFAOYSA-N 3-amino-n-methylsulfonylbenzamide Chemical compound CS(=O)(=O)NC(=O)C1=CC=CC(N)=C1 QSCZTRRXUFFZAI-UHFFFAOYSA-N 0.000 description 2
- HSBORVYMLHVKMB-UHFFFAOYSA-N 3-bromo-n-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]propanamide Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC1=C(Cl)C=CC(NC(=O)CCBr)=C1Cl HSBORVYMLHVKMB-UHFFFAOYSA-N 0.000 description 2
- DHSDXYOFOGILDT-UHFFFAOYSA-N 4-(3-aminophenyl)-n,n-dimethylbenzamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1C1=CC=CC(N)=C1 DHSDXYOFOGILDT-UHFFFAOYSA-N 0.000 description 2
- WNQUXRWZRJWTBX-UHFFFAOYSA-N 4-(3-methoxy-3-oxoprop-1-enyl)benzoic acid Chemical compound COC(=O)C=CC1=CC=C(C(O)=O)C=C1 WNQUXRWZRJWTBX-UHFFFAOYSA-N 0.000 description 2
- WDYXTBQUPCLKQQ-UHFFFAOYSA-N 4-(3-methoxy-3-oxopropyl)benzoic acid Chemical compound COC(=O)CCC1=CC=C(C(O)=O)C=C1 WDYXTBQUPCLKQQ-UHFFFAOYSA-N 0.000 description 2
- VJFCBNBTCCRDAA-UHFFFAOYSA-N 4-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl VJFCBNBTCCRDAA-UHFFFAOYSA-N 0.000 description 2
- XAGFYNSCWICYPA-UHFFFAOYSA-N 4-amino-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(N)C=C1 XAGFYNSCWICYPA-UHFFFAOYSA-N 0.000 description 2
- BRRVYBRXLUEEJP-UHFFFAOYSA-N 4-bromo-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=C(Br)C=C1 BRRVYBRXLUEEJP-UHFFFAOYSA-N 0.000 description 2
- HEJJOUODSJYXNF-UHFFFAOYSA-N 4-ethoxy-2-methylquinolin-8-ol Chemical compound C1=CC=C2C(OCC)=CC(C)=NC2=C1O HEJJOUODSJYXNF-UHFFFAOYSA-N 0.000 description 2
- GOUHYARYYWKXHS-UHFFFAOYSA-N 4-formylbenzoic acid Chemical compound OC(=O)C1=CC=C(C=O)C=C1 GOUHYARYYWKXHS-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- HPJNKHNVVUTIPV-UHFFFAOYSA-N 8-[(2,6-dimethoxy-3-nitrophenyl)methoxy]-2-methylquinoline Chemical compound COC1=CC=C([N+]([O-])=O)C(OC)=C1COC1=CC=CC2=CC=C(C)N=C12 HPJNKHNVVUTIPV-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- SOHAVULMGIITDH-UHFFFAOYSA-N Oxaline Natural products O=C1NC23N(OC)C4=CC=CC=C4C3(C(C)(C)C=C)C=C(OC)C(=O)N2C1=CC1=CN=CN1 SOHAVULMGIITDH-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 206010040070 Septic Shock Diseases 0.000 description 2
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 2
- 229910052776 Thorium Inorganic materials 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 2
- CLIRZNJVFKIINB-UHFFFAOYSA-N [2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl] acetate Chemical compound CC(=O)OCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl CLIRZNJVFKIINB-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 125000005116 aryl carbamoyl group Chemical group 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- DBJZHZBSERHVAL-UHFFFAOYSA-N ethyl 3,6-dimethylquinoline-2-carboxylate Chemical compound C1=C(C)C=C2C=C(C)C(C(=O)OCC)=NC2=C1 DBJZHZBSERHVAL-UHFFFAOYSA-N 0.000 description 2
- GZIAWYPUIUYLRF-UHFFFAOYSA-N ethyl 4-chloro-3,6-dimethylquinoline-2-carboxylate Chemical compound C1=C(C)C=C2C(Cl)=C(C)C(C(=O)OCC)=NC2=C1 GZIAWYPUIUYLRF-UHFFFAOYSA-N 0.000 description 2
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 2
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- BOWMIQFUGDEMSP-UHFFFAOYSA-N methyl 3-[4-(methylcarbamoyl)phenyl]prop-2-enoate Chemical compound CNC(=O)C1=CC=C(C=CC(=O)OC)C=C1 BOWMIQFUGDEMSP-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 2
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- RUPAXCPQAAOIPB-UHFFFAOYSA-N tert-butyl formate Chemical group CC(C)(C)OC=O RUPAXCPQAAOIPB-UHFFFAOYSA-N 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- SBOJVVSPAOOEEB-UHFFFAOYSA-N (2,6-dichloro-3-nitrophenyl)methanol Chemical compound OCC1=C(Cl)C=CC([N+]([O-])=O)=C1Cl SBOJVVSPAOOEEB-UHFFFAOYSA-N 0.000 description 1
- JHTZWHVXOTTWBW-UHFFFAOYSA-N (2,6-dimethoxy-3-nitrophenyl)methyl methanesulfonate Chemical compound COC1=CC=C([N+]([O-])=O)C(OC)=C1COS(C)(=O)=O JHTZWHVXOTTWBW-UHFFFAOYSA-N 0.000 description 1
- TXTWXQXDMWILOF-UHFFFAOYSA-N (2-ethoxy-2-oxoethyl)azanium;chloride Chemical compound [Cl-].CCOC(=O)C[NH3+] TXTWXQXDMWILOF-UHFFFAOYSA-N 0.000 description 1
- HFSIXGVASSRYJR-UHFFFAOYSA-N (2-methyl-8-phenylmethoxyquinolin-4-yl) trifluoromethanesulfonate Chemical compound C12=NC(C)=CC(OS(=O)(=O)C(F)(F)F)=C2C=CC=C1OCC1=CC=CC=C1 HFSIXGVASSRYJR-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- AADYWCBPJZAJNU-UHFFFAOYSA-N (3-methoxy-4-nitrophenyl)methanol Chemical compound COC1=CC(CO)=CC=C1[N+]([O-])=O AADYWCBPJZAJNU-UHFFFAOYSA-N 0.000 description 1
- RVYSKGNWKIIUIF-UHFFFAOYSA-N (4-amino-3-methoxyphenyl)methanol Chemical compound COC1=CC(CO)=CC=C1N RVYSKGNWKIIUIF-UHFFFAOYSA-N 0.000 description 1
- FUJZJBCWPIOHHN-QHHAFSJGSA-N (e)-1-phenylbut-2-en-1-one Chemical compound C\C=C\C(=O)C1=CC=CC=C1 FUJZJBCWPIOHHN-QHHAFSJGSA-N 0.000 description 1
- HEWGUPKUFYSZDV-GXDHUFHOSA-N (e)-3-(1-acetyl-3,4-dihydro-2h-quinolin-6-yl)-n-[2-[2,4-dichloro-n-methyl-3-[(2-methyl-4-morpholin-4-ylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]prop-2-enamide Chemical compound C=1C=C2N(C(C)=O)CCCC2=CC=1/C=C/C(=O)NCC(=O)N(C)C(C=1Cl)=CC=C(Cl)C=1COC(C1=NC(C)=C2)=CC=CC1=C2N1CCOCC1 HEWGUPKUFYSZDV-GXDHUFHOSA-N 0.000 description 1
- JMLMPCMUYNKOTB-GHRIWEEISA-N (e)-3-(1-acetyl-3,4-dihydro-2h-quinolin-6-yl)-n-[2-[2,4-dichloro-n-methyl-3-[(2-methyl-4-piperidin-1-ylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]prop-2-enamide Chemical compound C=1C=C2N(C(C)=O)CCCC2=CC=1/C=C/C(=O)NCC(=O)N(C)C(C=1Cl)=CC=C(Cl)C=1COC(C1=NC(C)=C2)=CC=CC1=C2N1CCCCC1 JMLMPCMUYNKOTB-GHRIWEEISA-N 0.000 description 1
- WXIOECXWDFNQIZ-SAPNQHFASA-N (e)-3-(1-acetyl-3,4-dihydro-2h-quinolin-6-yl)-n-[2-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-n,2,4-trimethylanilino]-2-oxoethyl]prop-2-enamide Chemical compound C1=C(C)N=C2C(OCC=3C(C)=CC=C(C=3C)N(C(=O)CNC(=O)\C=C\C=3C=C4CCCN(C4=CC=3)C(C)=O)C)=CC=CC2=C1C WXIOECXWDFNQIZ-SAPNQHFASA-N 0.000 description 1
- IVKNDURUEJGAKG-FNORWQNLSA-N (e)-3-(1-acetyl-3,4-dihydro-2h-quinolin-6-yl)prop-2-enoic acid Chemical compound OC(=O)/C=C/C1=CC=C2N(C(=O)C)CCCC2=C1 IVKNDURUEJGAKG-FNORWQNLSA-N 0.000 description 1
- XKDUSMDFTBTTGY-DUXPYHPUSA-N (e)-3-(1h-indol-5-yl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=C2NC=CC2=C1 XKDUSMDFTBTTGY-DUXPYHPUSA-N 0.000 description 1
- TUNHIDUCHRPZJR-NSCUHMNNSA-N (e)-3-(2-acetamidopyridin-4-yl)prop-2-enoic acid Chemical compound CC(=O)NC1=CC(\C=C\C(O)=O)=CC=N1 TUNHIDUCHRPZJR-NSCUHMNNSA-N 0.000 description 1
- VOVAHRIHPFNXQZ-QHHAFSJGSA-N (e)-3-(2-oxo-3,4-dihydro-1h-quinolin-6-yl)prop-2-enoic acid Chemical compound N1C(=O)CCC2=CC(/C=C/C(=O)O)=CC=C21 VOVAHRIHPFNXQZ-QHHAFSJGSA-N 0.000 description 1
- WGMFHSADKZJPGR-QPJJXVBHSA-N (e)-3-(4-acetamidophenyl)prop-2-enoic acid Chemical compound CC(=O)NC1=CC=C(\C=C\C(O)=O)C=C1 WGMFHSADKZJPGR-QPJJXVBHSA-N 0.000 description 1
- GJYZIPATHWWWOM-HEHNFIMWSA-N (e)-3-(6-acetamidopyridin-3-yl)-n-[2-[3-[[tert-butyl(diphenyl)silyl]oxymethyl]-2,4-dichloro-n-methylanilino]-2-oxoethyl]prop-2-enamide Chemical compound C=1C=C(Cl)C(CO[Si](C=2C=CC=CC=2)(C=2C=CC=CC=2)C(C)(C)C)=C(Cl)C=1N(C)C(=O)CNC(=O)\C=C\C1=CC=C(NC(C)=O)N=C1 GJYZIPATHWWWOM-HEHNFIMWSA-N 0.000 description 1
- DWEREWZBSHYWLZ-GQCTYLIASA-N (e)-3-(6-ethoxycarbonylpyridin-3-yl)prop-2-enoic acid Chemical compound CCOC(=O)C1=CC=C(\C=C\C(O)=O)C=N1 DWEREWZBSHYWLZ-GQCTYLIASA-N 0.000 description 1
- HHUZKOWAWVCZIO-GQCTYLIASA-N (e)-3-(6-ethoxypyridin-3-yl)prop-2-enoic acid Chemical compound CCOC1=CC=C(\C=C\C(O)=O)C=N1 HHUZKOWAWVCZIO-GQCTYLIASA-N 0.000 description 1
- XULFIMKYMXXHKE-GHRIWEEISA-N (e)-3-[6-(2-oxopyrrolidin-1-yl)pyridin-3-yl]-n-[2-oxo-2-[n,2,4-trimethyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]ethyl]prop-2-enamide Chemical compound C=1C=C(C)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(C)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1N1CCCC1=O XULFIMKYMXXHKE-GHRIWEEISA-N 0.000 description 1
- TURFHKJIRXKFHU-GQCTYLIASA-N (e)-3-[6-(2-oxopyrrolidin-1-yl)pyridin-3-yl]prop-2-enoic acid Chemical compound N1=CC(/C=C/C(=O)O)=CC=C1N1C(=O)CCC1 TURFHKJIRXKFHU-GQCTYLIASA-N 0.000 description 1
- QXZPQMFWFJBUNJ-HWKANZROSA-N (e)-3-[6-(methylamino)pyridin-3-yl]prop-2-enoic acid Chemical compound CNC1=CC=C(\C=C\C(O)=O)C=N1 QXZPQMFWFJBUNJ-HWKANZROSA-N 0.000 description 1
- WBHWJMHUCCDOBR-DMQCZMPNSA-N (e)-3-[6-[(e)-2-pyridin-2-ylethenyl]pyridin-3-yl]prop-2-enoic acid Chemical compound N1=CC(/C=C/C(=O)O)=CC=C1\C=C\C1=CC=CC=N1 WBHWJMHUCCDOBR-DMQCZMPNSA-N 0.000 description 1
- ZVKGCKXMRUJFAI-JENUQAQBSA-N (e)-3-[6-[(e)-2-pyridin-3-ylethenyl]pyridin-3-yl]prop-2-enoic acid Chemical compound N1=CC(/C=C/C(=O)O)=CC=C1\C=C\C1=CC=CN=C1 ZVKGCKXMRUJFAI-JENUQAQBSA-N 0.000 description 1
- KACRMJKLESZXKC-OJROMBEVSA-N (e)-3-[6-[(e)-2-pyridin-4-ylethenyl]pyridin-3-yl]prop-2-enoic acid Chemical compound N1=CC(/C=C/C(=O)O)=CC=C1\C=C\C1=CC=NC=C1 KACRMJKLESZXKC-OJROMBEVSA-N 0.000 description 1
- YBIWIEFOLKWDNV-AATRIKPKSA-N (e)-3-quinolin-3-ylprop-2-enoic acid Chemical compound C1=CC=CC2=CC(/C=C/C(=O)O)=CN=C21 YBIWIEFOLKWDNV-AATRIKPKSA-N 0.000 description 1
- KIOUOWRJHNDDFV-UKTHLTGXSA-N (e)-n-[2-[2,4-dichloro-3-[[4-(dimethylamino)-2-methylquinolin-8-yl]oxymethyl]-n-methylanilino]-2-oxoethyl]-3-[6-[(2-pyridin-4-ylacetyl)amino]pyridin-3-yl]prop-2-enamide Chemical compound C1=CC=C2C(N(C)C)=CC(C)=NC2=C1OCC(C=1Cl)=C(Cl)C=CC=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1NC(=O)CC1=CC=NC=C1 KIOUOWRJHNDDFV-UKTHLTGXSA-N 0.000 description 1
- UNNRQZHREKLRLD-YRNVUSSQSA-N (e)-n-[2-[2,4-dichloro-n-methyl-3-[(2-methyl-4-morpholin-4-ylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]-3-[6-[(2-pyridin-4-ylacetyl)amino]pyridin-3-yl]prop-2-enamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC(=C3C=CC=2)N2CCOCC2)=C(Cl)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1NC(=O)CC1=CC=NC=C1 UNNRQZHREKLRLD-YRNVUSSQSA-N 0.000 description 1
- GHPZWBVFASRINY-GXDHUFHOSA-N (e)-n-[2-[2,4-dichloro-n-methyl-3-[(2-methyl-4-piperidin-1-ylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]-3-[6-[(2-pyridin-4-ylacetyl)amino]pyridin-3-yl]prop-2-enamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC(=C3C=CC=2)N2CCCCC2)=C(Cl)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1NC(=O)CC1=CC=NC=C1 GHPZWBVFASRINY-GXDHUFHOSA-N 0.000 description 1
- OAAFTZUDQXISKK-BIUQSXLLSA-N (e)-n-[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]-3-[6-[(e)-2-pyridin-4-ylethenyl]pyridin-3-yl]prop-2-enamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1\C=C\C1=CC=NC=C1 OAAFTZUDQXISKK-BIUQSXLLSA-N 0.000 description 1
- LDYZWRBOVICGPQ-LFIBNONCSA-N (e)-n-[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]-3-[6-[[2-(2-methylpyridin-3-yl)acetyl]amino]pyridin-3-yl]prop-2-enamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1NC(=O)CC1=CC=CN=C1C LDYZWRBOVICGPQ-LFIBNONCSA-N 0.000 description 1
- INRZNNREMAQOGG-DTQAZKPQSA-N (e)-n-[2-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-n,2,4-trimethylanilino]-2-oxoethyl]-3-[6-(2-oxopyrrolidin-1-yl)pyridin-3-yl]prop-2-enamide Chemical compound C=1C=C(C)C(COC=2C3=NC(C)=CC(C)=C3C=CC=2)=C(C)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1N1CCCC1=O INRZNNREMAQOGG-DTQAZKPQSA-N 0.000 description 1
- WGENBQNEDVHFBD-DTQAZKPQSA-N (e)-n-[2-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-n,2,4-trimethylanilino]-2-oxoethyl]-3-[6-(ethylcarbamoylamino)pyridin-3-yl]prop-2-enamide Chemical compound C1=NC(NC(=O)NCC)=CC=C1\C=C\C(=O)NCC(=O)N(C)C1=CC=C(C)C(COC=2C3=NC(C)=CC(C)=C3C=CC=2)=C1C WGENBQNEDVHFBD-DTQAZKPQSA-N 0.000 description 1
- JCNMZGVWYNBDQA-PKQUXUPWSA-N (e)-n-[2-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-n,2,4-trimethylanilino]-2-oxoethyl]-3-[6-[(e)-2-pyridin-2-ylethenyl]pyridin-3-yl]prop-2-enamide Chemical compound C=1C=C(C)C(COC=2C3=NC(C)=CC(C)=C3C=CC=2)=C(C)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1\C=C\C1=CC=CC=N1 JCNMZGVWYNBDQA-PKQUXUPWSA-N 0.000 description 1
- UPDPWKPDCLIBTN-OYORFDRWSA-N (e)-n-[2-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-n,2,4-trimethylanilino]-2-oxoethyl]-3-[6-[(e)-2-pyridin-3-ylethenyl]pyridin-3-yl]prop-2-enamide Chemical compound C=1C=C(C)C(COC=2C3=NC(C)=CC(C)=C3C=CC=2)=C(C)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1\C=C\C1=CC=CN=C1 UPDPWKPDCLIBTN-OYORFDRWSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 description 1
- WBYGNQSYDUQZDZ-UHFFFAOYSA-N 1-(methylcarbamoyl)naphthalene-2-carboxylic acid Chemical compound CNC(=O)C=1C(=CC=C2C=CC=CC12)C(=O)O WBYGNQSYDUQZDZ-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 description 1
- UQPHYMRWABGMCI-UHFFFAOYSA-N 1-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]piperazine-2,5-dione Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC(C=1Cl)=C(Cl)C=CC=1N1CC(=O)NCC1=O UQPHYMRWABGMCI-UHFFFAOYSA-N 0.000 description 1
- HNBNXDLYGIVZCW-UHFFFAOYSA-N 1-acetyl-3,4-dihydro-2h-quinoline-6-carbaldehyde Chemical compound O=CC1=CC=C2N(C(=O)C)CCCC2=C1 HNBNXDLYGIVZCW-UHFFFAOYSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical compound O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 description 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- VOQFHIVAZVKLBF-UHFFFAOYSA-N 2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]aniline;dihydrochloride Chemical compound Cl.Cl.C12=NC(C)=CC=C2C=CC=C1OCC1=C(Cl)C=CC(N)=C1Cl VOQFHIVAZVKLBF-UHFFFAOYSA-N 0.000 description 1
- LGCVYYVOCKCISG-UHFFFAOYSA-N 2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]aniline Chemical compound CNC1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl LGCVYYVOCKCISG-UHFFFAOYSA-N 0.000 description 1
- HFZWRUODUSTPEG-UHFFFAOYSA-N 2,4-dichlorophenol Chemical compound OC1=CC=C(Cl)C=C1Cl HFZWRUODUSTPEG-UHFFFAOYSA-N 0.000 description 1
- BBUPBICWUURTNP-UHFFFAOYSA-N 2,4-dimethyl-1-nitrobenzene Chemical compound CC1=CC=C([N+]([O-])=O)C(C)=C1 BBUPBICWUURTNP-UHFFFAOYSA-N 0.000 description 1
- LHJFBVDNRPBOOW-UHFFFAOYSA-N 2,6-dichloro-3-hydroxybenzoic acid Chemical compound OC(=O)C1=C(Cl)C=CC(O)=C1Cl LHJFBVDNRPBOOW-UHFFFAOYSA-N 0.000 description 1
- GOGALNMBJIGJNW-UHFFFAOYSA-N 2,6-dimethyl-3-nitrobenzoic acid Chemical compound CC1=CC=C([N+]([O-])=O)C(C)=C1C(O)=O GOGALNMBJIGJNW-UHFFFAOYSA-N 0.000 description 1
- NQWYPNHFJRHOKO-UHFFFAOYSA-N 2-(1,3-benzothiazol-2-ylamino)acetic acid Chemical compound C1=CC=C2SC(NCC(=O)O)=NC2=C1 NQWYPNHFJRHOKO-UHFFFAOYSA-N 0.000 description 1
- FSRCSQUCNKVJIR-UHFFFAOYSA-N 2-(1,3-dioxoisoindol-2-yl)-n-[3-(hydroxymethyl)-2,4-dimethylphenyl]-n-methylacetamide Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(=O)N(C)C1=CC=C(C)C(CO)=C1C FSRCSQUCNKVJIR-UHFFFAOYSA-N 0.000 description 1
- FGGXHXRRJHMULM-UHFFFAOYSA-N 2-(1,3-dioxoisoindol-2-yl)-n-phenylacetamide Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(=O)NC1=CC=CC=C1 FGGXHXRRJHMULM-UHFFFAOYSA-N 0.000 description 1
- FVLYPXOSHYZOPT-UHFFFAOYSA-N 2-(1,3-dioxoisoindol-2-yl)propanoyl chloride Chemical compound C1=CC=C2C(=O)N(C(C)C(Cl)=O)C(=O)C2=C1 FVLYPXOSHYZOPT-UHFFFAOYSA-N 0.000 description 1
- CHZXTOCAICMPQR-UHFFFAOYSA-N 2-(2-bromoethyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCBr)C(=O)C2=C1 CHZXTOCAICMPQR-UHFFFAOYSA-N 0.000 description 1
- DWTRPWLHNATUPX-UHFFFAOYSA-N 2-(6-methylpyridin-3-yl)acetic acid Chemical compound CC1=CC=C(CC(O)=O)C=N1 DWTRPWLHNATUPX-UHFFFAOYSA-N 0.000 description 1
- ROARGNJULCPBPI-UHFFFAOYSA-N 2-(chloromethyl)-1,3-dimethoxy-4-nitrobenzene Chemical compound COC1=CC=C([N+]([O-])=O)C(OC)=C1CCl ROARGNJULCPBPI-UHFFFAOYSA-N 0.000 description 1
- LSCVJPYMXOAEPX-UHFFFAOYSA-N 2-(oxolan-2-yl)acetonitrile Chemical compound N#CCC1CCCO1 LSCVJPYMXOAEPX-UHFFFAOYSA-N 0.000 description 1
- PFHOSZAOXCYAGJ-UHFFFAOYSA-N 2-[(2-cyano-4-methoxy-4-methylpentan-2-yl)diazenyl]-4-methoxy-2,4-dimethylpentanenitrile Chemical compound COC(C)(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)(C)OC PFHOSZAOXCYAGJ-UHFFFAOYSA-N 0.000 description 1
- WNNCOODVYMTRAE-UHFFFAOYSA-N 2-[4-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-2,5-dioxopiperazin-1-yl]acetic acid Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC(C=1Cl)=C(Cl)C=CC=1N1CC(=O)N(CC(O)=O)CC1=O WNNCOODVYMTRAE-UHFFFAOYSA-N 0.000 description 1
- SXOGLZRMNGKCAB-UHFFFAOYSA-N 2-[8-[[2,6-dichloro-3-[methyl-[2-[3-[4-(methylcarbamoyl)phenyl]prop-2-enoylamino]acetyl]amino]phenyl]methoxy]-2-methylquinolin-4-yl]oxyacetic acid Chemical compound C1=CC(C(=O)NC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC(OCC(O)=O)=C3C=CC=2)=C1Cl SXOGLZRMNGKCAB-UHFFFAOYSA-N 0.000 description 1
- NGSAVMIENZDWKC-UHFFFAOYSA-N 2-[[2-(4-aminophenyl)sulfanylacetyl]amino]-n-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-n-methylacetamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)CSC1=CC=C(N)C=C1 NGSAVMIENZDWKC-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- NNNYDOYTZCKQPV-UHFFFAOYSA-N 2-amino-n-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]acetamide Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC1=C(Cl)C=CC(NC(=O)CN)=C1Cl NNNYDOYTZCKQPV-UHFFFAOYSA-N 0.000 description 1
- MNKYRFVZCRFAGX-UHFFFAOYSA-N 2-amino-n-[4-chloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-n-methylacetamide Chemical compound NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1 MNKYRFVZCRFAGX-UHFFFAOYSA-N 0.000 description 1
- GYDMPVHQWHCBOM-UHFFFAOYSA-N 2-amino-n-methyl-n-[2-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]acetamide Chemical compound NCC(=O)N(C)C1=CC=CC(COC=2C3=NC(C)=CC=C3C=CC=2)=C1C GYDMPVHQWHCBOM-UHFFFAOYSA-N 0.000 description 1
- UHGULLIUJBCTEF-UHFFFAOYSA-N 2-aminobenzothiazole Chemical compound C1=CC=C2SC(N)=NC2=C1 UHGULLIUJBCTEF-UHFFFAOYSA-N 0.000 description 1
- LSTRKXWIZZZYAS-UHFFFAOYSA-N 2-bromoacetyl bromide Chemical compound BrCC(Br)=O LSTRKXWIZZZYAS-UHFFFAOYSA-N 0.000 description 1
- IZBCMTUGWCACFY-UHFFFAOYSA-N 2-diazonio-1-(2-methylpyridin-3-yl)ethenolate Chemical compound CC1=NC=CC=C1C(=O)C=[N+]=[N-] IZBCMTUGWCACFY-UHFFFAOYSA-N 0.000 description 1
- 125000003635 2-dimethylaminoethoxy group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 description 1
- FZEHZVUFWWFCMN-UHFFFAOYSA-N 2-methoxycarbonyl-3-methylquinoline-6-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2C=C(C)C(C(=O)OC)=NC2=C1 FZEHZVUFWWFCMN-UHFFFAOYSA-N 0.000 description 1
- NKIYWQXHGLYLIA-UHFFFAOYSA-N 2-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]aniline Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC1=CC=CC(N)=C1C NKIYWQXHGLYLIA-UHFFFAOYSA-N 0.000 description 1
- QCEYXLPBTZCAKG-UHFFFAOYSA-N 2-methyl-3-phenylmethoxyquinoline Chemical compound CC1=NC2=CC=CC=C2C=C1OCC1=CC=CC=C1 QCEYXLPBTZCAKG-UHFFFAOYSA-N 0.000 description 1
- SFLXAJQWTISFEB-UHFFFAOYSA-N 2-methyl-4-(4-methylpiperazin-1-yl)quinolin-8-ol;hydrochloride Chemical compound Cl.C1CN(C)CCN1C1=CC(C)=NC2=C(O)C=CC=C12 SFLXAJQWTISFEB-UHFFFAOYSA-N 0.000 description 1
- KAFXKKXEIVYXAV-UHFFFAOYSA-N 2-methyl-4-piperidin-1-ylquinolin-8-ol Chemical compound C=12C=CC=C(O)C2=NC(C)=CC=1N1CCCCC1 KAFXKKXEIVYXAV-UHFFFAOYSA-N 0.000 description 1
- WFPIEQQJWGRVBB-UHFFFAOYSA-N 2-methyl-4-propan-2-yloxyquinolin-8-ol Chemical compound C1=CC=C2C(OC(C)C)=CC(C)=NC2=C1O WFPIEQQJWGRVBB-UHFFFAOYSA-N 0.000 description 1
- AKVNGMALILJRPA-UHFFFAOYSA-N 2-methyl-4-propoxyquinolin-8-ol Chemical compound C1=CC=C2C(OCCC)=CC(C)=NC2=C1O AKVNGMALILJRPA-UHFFFAOYSA-N 0.000 description 1
- JHWJFDBZHAUCDG-UHFFFAOYSA-N 2-methyl-4-pyrrolidin-1-ylquinolin-8-ol Chemical compound C=12C=CC=C(O)C2=NC(C)=CC=1N1CCCC1 JHWJFDBZHAUCDG-UHFFFAOYSA-N 0.000 description 1
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- QMDTXWRBNMIIMQ-UHFFFAOYSA-N 2-methyl-8-[(2-methyl-3-nitrophenyl)methoxy]quinoline Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC1=CC=CC([N+]([O-])=O)=C1C QMDTXWRBNMIIMQ-UHFFFAOYSA-N 0.000 description 1
- DVSHGMHSDZQSFW-DTQAZKPQSA-N 2-methyl-n-[5-[(e)-3-oxo-3-[[2-oxo-2-[n,2,4-trimethyl-3-[(3-methylquinoxalin-5-yl)oxymethyl]anilino]ethyl]amino]prop-1-enyl]pyridin-2-yl]pyridine-3-carboxamide Chemical compound C=1C=C(C)C(COC=2C3=NC(C)=CN=C3C=CC=2)=C(C)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1NC(=O)C1=CC=CN=C1C DVSHGMHSDZQSFW-DTQAZKPQSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- JRYYVMDEUJQWRO-UHFFFAOYSA-N 2-methylnicotinamide Chemical compound CC1=NC=CC=C1C(N)=O JRYYVMDEUJQWRO-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical class CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- HNTZKNJGAFJMHQ-UHFFFAOYSA-N 2-methylpyridine-3-carboxylic acid Chemical compound CC1=NC=CC=C1C(O)=O HNTZKNJGAFJMHQ-UHFFFAOYSA-N 0.000 description 1
- 125000001216 2-naphthoyl group Chemical group C1=C(C=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- PLPVLSBYYOWFKM-UHFFFAOYSA-N 2-phenylmethoxyaniline Chemical compound NC1=CC=CC=C1OCC1=CC=CC=C1 PLPVLSBYYOWFKM-UHFFFAOYSA-N 0.000 description 1
- UTVPAOAMOARXMB-UHFFFAOYSA-N 3-(4-acetamido-3-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC(C=CC(O)=O)=CC=C1NC(C)=O UTVPAOAMOARXMB-UHFFFAOYSA-N 0.000 description 1
- KCNYFGBDSUEYAU-UHFFFAOYSA-N 3-(4-acetamido-3-methylphenyl)prop-2-enoic acid Chemical compound CC(=O)NC1=CC=C(C=CC(O)=O)C=C1C KCNYFGBDSUEYAU-UHFFFAOYSA-N 0.000 description 1
- QNPCATFSSWARPZ-UHFFFAOYSA-N 3-(4-aminophenyl)-n-[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]prop-2-enamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)C=CC1=CC=C(N)C=C1 QNPCATFSSWARPZ-UHFFFAOYSA-N 0.000 description 1
- OHBNYXJULUDUBF-UHFFFAOYSA-N 3-(6-acetamidopyridin-3-yl)propanoic acid Chemical compound CC(=O)NC1=CC=C(CCC(O)=O)C=N1 OHBNYXJULUDUBF-UHFFFAOYSA-N 0.000 description 1
- NMCBWICNRJLKKM-UHFFFAOYSA-N 3-(benzyloxy)pyridin-2-amine Chemical compound NC1=NC=CC=C1OCC1=CC=CC=C1 NMCBWICNRJLKKM-UHFFFAOYSA-N 0.000 description 1
- PEFUILABTLLEFG-WAYWQWQTSA-N 3-[(z)-2-[4-(methylcarbamoyl)phenyl]ethenyl]benzoic acid Chemical compound C1=CC(C(=O)NC)=CC=C1\C=C/C1=CC=CC(C(O)=O)=C1 PEFUILABTLLEFG-WAYWQWQTSA-N 0.000 description 1
- FIEQAXDVHHHMAH-UHFFFAOYSA-N 3-[4-(2-oxopyrrolidin-1-yl)phenyl]-n-[2-oxo-2-[n,2,4-trimethyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]ethyl]prop-2-enamide Chemical compound C=1C=C(C)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(C)C=1N(C)C(=O)CNC(=O)C=CC(C=C1)=CC=C1N1CCCC1=O FIEQAXDVHHHMAH-UHFFFAOYSA-N 0.000 description 1
- WNGLICQFLTUTBR-UHFFFAOYSA-N 3-[4-(methylcarbamoyl)phenyl]propanoic acid Chemical compound CNC(=O)C1=CC=C(CCC(O)=O)C=C1 WNGLICQFLTUTBR-UHFFFAOYSA-N 0.000 description 1
- GGQWWGBJGYLHMJ-UHFFFAOYSA-N 3-[[tert-butyl(diphenyl)silyl]oxymethyl]-2,4,6-trimethylaniline Chemical compound CC1=C(N)C(C)=CC(C)=C1CO[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 GGQWWGBJGYLHMJ-UHFFFAOYSA-N 0.000 description 1
- MYXKGFLNLYDIRH-UHFFFAOYSA-N 3-amino-n-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-n-methylpropanamide Chemical compound NCCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl MYXKGFLNLYDIRH-UHFFFAOYSA-N 0.000 description 1
- PYDQTASEULDNRL-UHFFFAOYSA-N 3-amino-n-methylbenzamide Chemical compound CNC(=O)C1=CC=CC(N)=C1 PYDQTASEULDNRL-UHFFFAOYSA-N 0.000 description 1
- IHBVNSPHKMCPST-UHFFFAOYSA-N 3-bromopropanoyl chloride Chemical compound ClC(=O)CCBr IHBVNSPHKMCPST-UHFFFAOYSA-N 0.000 description 1
- RERQSNVRWGQJNP-UHFFFAOYSA-N 3-methylquinoxalin-5-ol Chemical compound C1=CC=C(O)C2=NC(C)=CN=C21 RERQSNVRWGQJNP-UHFFFAOYSA-N 0.000 description 1
- JWGSDGYKDDKOEB-UHFFFAOYSA-N 4-(2-methoxyethoxy)-2-methylquinolin-8-ol Chemical compound C1=CC=C2C(OCCOC)=CC(C)=NC2=C1O JWGSDGYKDDKOEB-UHFFFAOYSA-N 0.000 description 1
- BFCWWODHUUOLAJ-UHFFFAOYSA-N 4-(azepan-1-yl)-2-methylquinolin-8-ol Chemical compound C=12C=CC=C(O)C2=NC(C)=CC=1N1CCCCCC1 BFCWWODHUUOLAJ-UHFFFAOYSA-N 0.000 description 1
- XKPXNVTZZUYYKJ-UHFFFAOYSA-N 4-(hydroxymethyl)-2-methylquinolin-8-ol Chemical compound C1=CC=C(O)C2=NC(C)=CC(CO)=C21 XKPXNVTZZUYYKJ-UHFFFAOYSA-N 0.000 description 1
- CWVAZQWTWYATDJ-UHFFFAOYSA-N 4-(methoxymethyl)-2-methylquinolin-8-ol Chemical compound C1=CC=C2C(COC)=CC(C)=NC2=C1O CWVAZQWTWYATDJ-UHFFFAOYSA-N 0.000 description 1
- FSKNVFDOAFGNRT-UHFFFAOYSA-N 4-[2-(dimethylamino)ethylamino]-2-methylquinolin-8-ol;hydrochloride Chemical compound Cl.C1=CC=C2C(NCCN(C)C)=CC(C)=NC2=C1O FSKNVFDOAFGNRT-UHFFFAOYSA-N 0.000 description 1
- GXDNRARFXKDKJC-UHFFFAOYSA-N 4-[3-(methylamino)-3-oxoprop-1-enyl]benzoic acid Chemical compound CNC(=O)C=CC1=CC=C(C(O)=O)C=C1 GXDNRARFXKDKJC-UHFFFAOYSA-N 0.000 description 1
- LJHJDJHVUGHJGR-UHFFFAOYSA-N 4-[3-[[2-[2,4-dichloro-3-(hydroxymethyl)-n-methylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(Cl)C(CO)=C1Cl LJHJDJHVUGHJGR-UHFFFAOYSA-N 0.000 description 1
- VLHYNZWTEQUTEB-UHFFFAOYSA-N 4-[3-[[2-[2,4-dichloro-3-[(4-chloro-2,3-dimethylquinolin-8-yl)oxymethyl]-n-methylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=C(C)C(Cl)=C3C=CC=2)=C1Cl VLHYNZWTEQUTEB-UHFFFAOYSA-N 0.000 description 1
- ULPFVSSABROTQU-UHFFFAOYSA-N 4-[3-[[2-[2,4-dichloro-3-[[4-(dimethylamino)-2-methylquinolin-8-yl]oxymethyl]-n-methylanilino]-2-oxoethyl]amino]-3-oxopropyl]-n-(pyridin-2-ylmethyl)benzamide Chemical compound C1=CC=C2C(N(C)C)=CC(C)=NC2=C1OCC(C=1Cl)=C(Cl)C=CC=1N(C)C(=O)CNC(=O)CCC(C=C1)=CC=C1C(=O)NCC1=CC=CC=N1 ULPFVSSABROTQU-UHFFFAOYSA-N 0.000 description 1
- NRSKJWGWIFRFFX-UHFFFAOYSA-N 4-[3-[[2-[2,4-dichloro-n-methyl-3-[(2-methyl-4-morpholin-4-ylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-2-methoxy-n-methylbenzamide Chemical compound C1=C(OC)C(C(=O)NC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC(=C3C=CC=2)N2CCOCC2)=C1Cl NRSKJWGWIFRFFX-UHFFFAOYSA-N 0.000 description 1
- BLPFDPXVARUKLC-UHFFFAOYSA-N 4-[3-[[2-[2,4-dichloro-n-methyl-3-[(2-methyl-4-piperidin-1-ylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-2-methoxy-n-methylbenzamide Chemical compound C1=C(OC)C(C(=O)NC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC(=C3C=CC=2)N2CCCCC2)=C1Cl BLPFDPXVARUKLC-UHFFFAOYSA-N 0.000 description 1
- GFPMPASAIQQEDG-UHFFFAOYSA-N 4-[3-[[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-2-methoxy-n-methylbenzamide Chemical compound C1=C(OC)C(C(=O)NC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl GFPMPASAIQQEDG-UHFFFAOYSA-N 0.000 description 1
- XZERMVBWFJENLS-UHFFFAOYSA-N 4-[3-[[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl XZERMVBWFJENLS-UHFFFAOYSA-N 0.000 description 1
- GQOBRKVINZPHJP-UHFFFAOYSA-N 4-[3-[[2-[2,4-dimethoxy-N-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-N-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(OC)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1OC GQOBRKVINZPHJP-UHFFFAOYSA-N 0.000 description 1
- ICXRHIWXBKMUPC-UHFFFAOYSA-N 4-[3-[[2-[3-(chloromethyl)-n,2,4-trimethylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(C)C(CCl)=C1C ICXRHIWXBKMUPC-UHFFFAOYSA-N 0.000 description 1
- WYOUUGARDUJDJP-UHFFFAOYSA-N 4-[3-[[2-[3-(hydroxymethyl)-n,2,4-trimethylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-n-methylbenzamide Chemical compound C1=CC(C(=O)NC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(C)C(CO)=C1C WYOUUGARDUJDJP-UHFFFAOYSA-N 0.000 description 1
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 1
- DENKGPBHLYFNGK-UHFFFAOYSA-N 4-bromobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Br)C=C1 DENKGPBHLYFNGK-UHFFFAOYSA-N 0.000 description 1
- GRHQDJDRGZFIPO-UHFFFAOYSA-N 4-bromobutanoic acid Chemical compound OC(=O)CCCBr GRHQDJDRGZFIPO-UHFFFAOYSA-N 0.000 description 1
- LRTRXDSAJLSRTG-UHFFFAOYSA-N 4-bromobutanoyl chloride Chemical compound ClC(=O)CCCBr LRTRXDSAJLSRTG-UHFFFAOYSA-N 0.000 description 1
- HAEJSGLKJYIYTB-ZZXKWVIFSA-N 4-carboxycinnamic acid Chemical compound OC(=O)\C=C\C1=CC=C(C(O)=O)C=C1 HAEJSGLKJYIYTB-ZZXKWVIFSA-N 0.000 description 1
- FABVUTPEAPHOPB-UHFFFAOYSA-N 4-chloro-2,3-dimethylquinolin-8-ol Chemical compound C1=CC=C2C(Cl)=C(C)C(C)=NC2=C1O FABVUTPEAPHOPB-UHFFFAOYSA-N 0.000 description 1
- BRFUUPGEUVCNCX-UHFFFAOYSA-N 4-chloro-3-[(2-methylquinolin-8-yl)oxymethyl]aniline Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC1=CC(N)=CC=C1Cl BRFUUPGEUVCNCX-UHFFFAOYSA-N 0.000 description 1
- UTAATMOEMZYPDP-UHFFFAOYSA-N 4-chloro-8-[(2,6-dichloro-3-nitrophenyl)methoxy]-2-methylquinoline Chemical compound C12=NC(C)=CC(Cl)=C2C=CC=C1OCC1=C(Cl)C=CC([N+]([O-])=O)=C1Cl UTAATMOEMZYPDP-UHFFFAOYSA-N 0.000 description 1
- PDGFBMZSKDOZLF-UHFFFAOYSA-N 4-chloro-8-methoxy-2,3-dimethylquinoline Chemical compound CC1=C(C)N=C2C(OC)=CC=CC2=C1Cl PDGFBMZSKDOZLF-UHFFFAOYSA-N 0.000 description 1
- FSZSWMIHAOSEMS-UHFFFAOYSA-N 4-cyclopentyloxy-2-methylquinolin-8-ol Chemical compound C=12C=CC=C(O)C2=NC(C)=CC=1OC1CCCC1 FSZSWMIHAOSEMS-UHFFFAOYSA-N 0.000 description 1
- GAPFKQSMCBHKRO-UHFFFAOYSA-N 4-ethenyl-2-methyl-8-phenylmethoxyquinoline Chemical compound C12=NC(C)=CC(C=C)=C2C=CC=C1OCC1=CC=CC=C1 GAPFKQSMCBHKRO-UHFFFAOYSA-N 0.000 description 1
- ZLQTWPZVBKRULK-UHFFFAOYSA-N 4-methoxy-2-methylquinolin-8-ol Chemical compound C1=CC=C2C(OC)=CC(C)=NC2=C1O ZLQTWPZVBKRULK-UHFFFAOYSA-N 0.000 description 1
- ROURUXKJOMAGMI-GXDHUFHOSA-N 5-[(e)-3-[[2-[2,4-dichloro-3-[[4-(dimethylamino)-2-methylquinolin-8-yl]oxymethyl]-n-methylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-n-methylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1\C=C\C(=O)NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC(=C3C=CC=2)N(C)C)=C1Cl ROURUXKJOMAGMI-GXDHUFHOSA-N 0.000 description 1
- NKJKSLWLMUIYQT-XYOKQWHBSA-N 5-[(e)-3-[[2-[2,4-dichloro-n-methyl-3-[(2-methyl-4-morpholin-4-ylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-n-methylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1\C=C\C(=O)NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC(=C3C=CC=2)N2CCOCC2)=C1Cl NKJKSLWLMUIYQT-XYOKQWHBSA-N 0.000 description 1
- USLRRNBBSUSKNQ-MDWZMJQESA-N 5-[(e)-3-[[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-n-(1,3-thiazol-2-yl)pyridine-2-carboxamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1C(=O)NC1=NC=CS1 USLRRNBBSUSKNQ-MDWZMJQESA-N 0.000 description 1
- ZKYWBLYQGXBYCF-SAPNQHFASA-N 5-[(e)-3-[[2-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-n,2,4-trimethylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-n-(pyridin-2-ylmethyl)pyridine-2-carboxamide Chemical compound C=1C=C(C)C(COC=2C3=NC(C)=CC(C)=C3C=CC=2)=C(C)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1C(=O)NCC1=CC=CC=N1 ZKYWBLYQGXBYCF-SAPNQHFASA-N 0.000 description 1
- GDGIVSREGUOIJZ-UHFFFAOYSA-N 5-amino-3h-1,3,4-thiadiazole-2-thione Chemical compound NC1=NN=C(S)S1 GDGIVSREGUOIJZ-UHFFFAOYSA-N 0.000 description 1
- NTUGOUQFCZEQHP-HWKANZROSA-N 6-[(e)-2-pyridin-3-ylethenyl]pyridine-3-carbaldehyde Chemical compound N1=CC(C=O)=CC=C1\C=C\C1=CC=CN=C1 NTUGOUQFCZEQHP-HWKANZROSA-N 0.000 description 1
- PUYFNHSGYGODTP-HNQUOIGGSA-N 6-[(e)-2-pyridin-4-ylethenyl]pyridine-3-carbaldehyde Chemical compound N1=CC(C=O)=CC=C1\C=C\C1=CC=NC=C1 PUYFNHSGYGODTP-HNQUOIGGSA-N 0.000 description 1
- OHXIELRUKRZARR-UHFFFAOYSA-N 6-[[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]carbamoyl]-3-methylquinoline-2-carboxylic acid Chemical compound C1=C(C)N=C2C(OCC=3C(Cl)=CC=C(C=3Cl)N(C(=O)CNC(=O)C=3C=C4C=C(C)C(C(O)=O)=NC4=CC=3)C)=CC=CC2=C1 OHXIELRUKRZARR-UHFFFAOYSA-N 0.000 description 1
- ROARRKDOMGZNFY-UHFFFAOYSA-N 6-ethoxypyridine-3-carbaldehyde Chemical compound CCOC1=CC=C(C=O)C=N1 ROARRKDOMGZNFY-UHFFFAOYSA-N 0.000 description 1
- RZOKQIPOABEQAM-UHFFFAOYSA-N 6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)C=N1 RZOKQIPOABEQAM-UHFFFAOYSA-N 0.000 description 1
- HYIPHECUSUQGAM-UHFFFAOYSA-N 8-[(2,6-dichloro-3-nitrophenyl)methoxy]-2-methylquinoline Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC1=C(Cl)C=CC([N+]([O-])=O)=C1Cl HYIPHECUSUQGAM-UHFFFAOYSA-N 0.000 description 1
- NIBQYKGZIPWOMW-UHFFFAOYSA-N 8-[(2,6-dichloro-3-nitrophenyl)methoxy]-4-methoxy-2-methylquinoline Chemical compound C1=CC=C2C(OC)=CC(C)=NC2=C1OCC1=C(Cl)C=CC([N+]([O-])=O)=C1Cl NIBQYKGZIPWOMW-UHFFFAOYSA-N 0.000 description 1
- FIHMZCZMRCEXDD-UHFFFAOYSA-N 8-[(2,6-dimethyl-3-nitrophenyl)methoxy]-2-methylquinoline Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC1=C(C)C=CC([N+]([O-])=O)=C1C FIHMZCZMRCEXDD-UHFFFAOYSA-N 0.000 description 1
- NSOTWHLTHPOMDZ-UHFFFAOYSA-N 8-[(2-chloro-5-nitrophenyl)methoxy]-2-methylquinoline Chemical compound C12=NC(C)=CC=C2C=CC=C1OCC1=CC([N+]([O-])=O)=CC=C1Cl NSOTWHLTHPOMDZ-UHFFFAOYSA-N 0.000 description 1
- YZDOYTGJPJYDPO-UHFFFAOYSA-N 8-[[2,6-dimethyl-3-[methyl-[2-[3-[4-(methylcarbamoyl)phenyl]prop-2-enoylamino]acetyl]amino]phenyl]methoxy]-2-methylquinoline-4-carboxylic acid Chemical compound C1=CC(C(=O)NC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(C)C(COC=2C3=NC(C)=CC(=C3C=CC=2)C(O)=O)=C1C YZDOYTGJPJYDPO-UHFFFAOYSA-N 0.000 description 1
- FWEOQOXTVHGIFQ-UHFFFAOYSA-N 8-anilinonaphthalene-1-sulfonic acid Chemical compound C=12C(S(=O)(=O)O)=CC=CC2=CC=CC=1NC1=CC=CC=C1 FWEOQOXTVHGIFQ-UHFFFAOYSA-N 0.000 description 1
- LMMVFCGRHXWUKR-UHFFFAOYSA-N 8-methoxy-2,3-dimethyl-1h-quinolin-4-one Chemical compound CC1=C(C)N=C2C(OC)=CC=CC2=C1O LMMVFCGRHXWUKR-UHFFFAOYSA-N 0.000 description 1
- FJNCXZZQNBKEJT-UHFFFAOYSA-N 8beta-hydroxymarrubiin Natural products O1C(=O)C2(C)CCCC3(C)C2C1CC(C)(O)C3(O)CCC=1C=COC=1 FJNCXZZQNBKEJT-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- SSUFDOMYCBCHML-UHFFFAOYSA-N CCCCC[S](=O)=O Chemical group CCCCC[S](=O)=O SSUFDOMYCBCHML-UHFFFAOYSA-N 0.000 description 1
- 206010058019 Cancer Pain Diseases 0.000 description 1
- 206010007270 Carcinoid syndrome Diseases 0.000 description 1
- QPSHNUMOFADCFF-UHFFFAOYSA-N Cl.Cl.[P] Chemical compound Cl.Cl.[P] QPSHNUMOFADCFF-UHFFFAOYSA-N 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 206010022941 Iridocyclitis Diseases 0.000 description 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- IBHGHSNKKUVDPF-LHVDUAEASA-N N-[2-[2,4-dichloro-N-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]-3-[4-[(E)-2-pyridin-4-ylethenyl]phenyl]prop-2-enamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)C=CC(C=C1)=CC=C1\C=C\C1=CC=NC=C1 IBHGHSNKKUVDPF-LHVDUAEASA-N 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methyl-N-phenylamine Natural products CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical group 0.000 description 1
- 208000011623 Obstructive Lung disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010030216 Oesophagitis Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037083 Prurigo Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 206010066371 Tendon pain Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- LAVVAIBBDLWYJI-HNQUOIGGSA-N [6-[(e)-2-pyridin-4-ylethenyl]pyridin-3-yl]methanol Chemical compound N1=CC(CO)=CC=C1\C=C\C1=CC=NC=C1 LAVVAIBBDLWYJI-HNQUOIGGSA-N 0.000 description 1
- DGYIJVNZSDYBOE-UHFFFAOYSA-N [CH2]C1=CC=NC=C1 Chemical group [CH2]C1=CC=NC=C1 DGYIJVNZSDYBOE-UHFFFAOYSA-N 0.000 description 1
- WGPAQYSVWYWZKT-UHFFFAOYSA-N [C].[Ra] Chemical compound [C].[Ra] WGPAQYSVWYWZKT-UHFFFAOYSA-N 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- QGLZXHRNAYXIBU-WEVVVXLNSA-N aldicarb Chemical compound CNC(=O)O\N=C\C(C)(C)SC QGLZXHRNAYXIBU-WEVVVXLNSA-N 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 201000004612 anterior uveitis Diseases 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- FYXKZNLBZKRYSS-UHFFFAOYSA-N benzene-1,2-dicarbonyl chloride Chemical compound ClC(=O)C1=CC=CC=C1C(Cl)=O FYXKZNLBZKRYSS-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- GTXRYQGMNAPQDP-UHFFFAOYSA-N butyl-chloro-diphenylsilane Chemical group C=1C=CC=CC=1[Si](Cl)(CCCC)C1=CC=CC=C1 GTXRYQGMNAPQDP-UHFFFAOYSA-N 0.000 description 1
- DLIJPAHLBJIQHE-UHFFFAOYSA-N butylphosphane Chemical compound CCCCP DLIJPAHLBJIQHE-UHFFFAOYSA-N 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical group 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000002592 cumenyl group Chemical group C1(=C(C=CC=C1)*)C(C)C 0.000 description 1
- 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- RNOJZAYWQCKGRK-UHFFFAOYSA-N diazene hydrochloride Chemical compound Cl.N=N RNOJZAYWQCKGRK-UHFFFAOYSA-N 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- WBKFWQBXFREOFH-UHFFFAOYSA-N dichloromethane;ethyl acetate Chemical compound ClCCl.CCOC(C)=O WBKFWQBXFREOFH-UHFFFAOYSA-N 0.000 description 1
- SPWVRYZQLGQKGK-UHFFFAOYSA-N dichloromethane;hexane Chemical compound ClCCl.CCCCCC SPWVRYZQLGQKGK-UHFFFAOYSA-N 0.000 description 1
- OQOCQBJWOCRPQY-UHFFFAOYSA-N diethyl 2-methyl-3-oxosuccinate Chemical compound CCOC(=O)C(C)C(=O)C(=O)OCC OQOCQBJWOCRPQY-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 208000006881 esophagitis Diseases 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- KUGSJJNCCNSRMM-UHFFFAOYSA-N ethoxyboronic acid Chemical compound CCOB(O)O KUGSJJNCCNSRMM-UHFFFAOYSA-N 0.000 description 1
- IVQZCBBKHSGPQM-UHFFFAOYSA-N ethyl 2,6-dichloro-3-(methoxymethoxy)benzoate Chemical compound CCOC(=O)C1=C(Cl)C=CC(OCOC)=C1Cl IVQZCBBKHSGPQM-UHFFFAOYSA-N 0.000 description 1
- LWMAVYXLIVTJJH-UHFFFAOYSA-N ethyl 2,6-dichloro-3-hydroxybenzoate Chemical compound CCOC(=O)C1=C(Cl)C=CC(O)=C1Cl LWMAVYXLIVTJJH-UHFFFAOYSA-N 0.000 description 1
- DZQVUPASCKTNGL-UHFFFAOYSA-N ethyl 2-(2-methyl-8-phenylmethoxyquinolin-4-yl)oxyacetate Chemical compound C1=CC=C2C(OCC(=O)OCC)=CC(C)=NC2=C1OCC1=CC=CC=C1 DZQVUPASCKTNGL-UHFFFAOYSA-N 0.000 description 1
- NTNZTEQNFHNYBC-UHFFFAOYSA-N ethyl 2-aminoacetate Chemical class CCOC(=O)CN NTNZTEQNFHNYBC-UHFFFAOYSA-N 0.000 description 1
- OCUUFPFHMAUBEY-UHFFFAOYSA-N ethyl 2-methyl-8-phenylmethoxyquinoline-4-carboxylate Chemical compound C1=CC=C2C(C(=O)OCC)=CC(C)=NC2=C1OCC1=CC=CC=C1 OCUUFPFHMAUBEY-UHFFFAOYSA-N 0.000 description 1
- YCBJOQUNPLTBGG-UHFFFAOYSA-N ethyl 4-iodobenzoate Chemical compound CCOC(=O)C1=CC=C(I)C=C1 YCBJOQUNPLTBGG-UHFFFAOYSA-N 0.000 description 1
- LBJWBHBYXFWITL-DTQAZKPQSA-N ethyl 5-[(e)-3-[[2-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-n,2,4-trimethylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]pyridine-2-carboxylate Chemical compound C1=NC(C(=O)OCC)=CC=C1\C=C\C(=O)NCC(=O)N(C)C1=CC=C(C)C(COC=2C3=NC(C)=CC(C)=C3C=CC=2)=C1C LBJWBHBYXFWITL-DTQAZKPQSA-N 0.000 description 1
- VGAAJNIKKFGQQN-UHFFFAOYSA-N ethyl 6-(acetyloxymethyl)-3-methylquinoline-2-carboxylate Chemical compound C1=C(COC(C)=O)C=C2C=C(C)C(C(=O)OCC)=NC2=C1 VGAAJNIKKFGQQN-UHFFFAOYSA-N 0.000 description 1
- KQADDJCWFIKACN-UHFFFAOYSA-N ethyl 6-(bromomethyl)-3-methylquinoline-2-carboxylate Chemical compound C1=C(CBr)C=C2C=C(C)C(C(=O)OCC)=NC2=C1 KQADDJCWFIKACN-UHFFFAOYSA-N 0.000 description 1
- ITKPBTMHTNCFOA-UHFFFAOYSA-N ethyl 8-hydroxy-2-methylquinoline-4-carboxylate Chemical compound C1=CC=C2C(C(=O)OCC)=CC(C)=NC2=C1O ITKPBTMHTNCFOA-UHFFFAOYSA-N 0.000 description 1
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- JUOXYWXXPHUSAI-UHFFFAOYSA-N ethylamino acetate Chemical compound CCNOC(C)=O JUOXYWXXPHUSAI-UHFFFAOYSA-N 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960004979 fampridine Drugs 0.000 description 1
- 229940044631 ferric chloride hexahydrate Drugs 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 238000013110 gastrectomy Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000011597 hartley guinea pig Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- MOTRZVVGCFFABN-UHFFFAOYSA-N hexane;2-propan-2-yloxypropane Chemical compound CCCCCC.CC(C)OC(C)C MOTRZVVGCFFABN-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005935 hexyloxycarbonyl group Chemical group 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- BNTRVUUJBGBGLZ-UHFFFAOYSA-N hydron;pyridine-4-carbonyl chloride;chloride Chemical compound Cl.ClC(=O)C1=CC=NC=C1 BNTRVUUJBGBGLZ-UHFFFAOYSA-N 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000005945 imidazopyridyl group Chemical group 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 208000001286 intracranial vasospasm Diseases 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 201000004614 iritis Diseases 0.000 description 1
- NQXWGWZJXJUMQB-UHFFFAOYSA-K iron trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].Cl[Fe+]Cl NQXWGWZJXJUMQB-UHFFFAOYSA-K 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- JMZFEHDNIAQMNB-UHFFFAOYSA-N m-aminophenylboronic acid Chemical compound NC1=CC=CC(B(O)O)=C1 JMZFEHDNIAQMNB-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- FBBDOOHMGLLEGJ-UHFFFAOYSA-N methane;hydrochloride Chemical compound C.Cl FBBDOOHMGLLEGJ-UHFFFAOYSA-N 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- RHMQNXNXUZLEIY-UHFFFAOYSA-N methanol;2-propan-2-yloxypropane Chemical compound OC.CC(C)OC(C)C RHMQNXNXUZLEIY-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 1
- DDAHODSRFCRULG-UHFFFAOYSA-N methoxymethoxybenzene Chemical compound COCOC1=CC=CC=C1 DDAHODSRFCRULG-UHFFFAOYSA-N 0.000 description 1
- SIURSMPFFMLOEH-HWKANZROSA-N methyl (e)-3-(6-aminopyridin-3-yl)prop-2-enoate Chemical compound COC(=O)\C=C\C1=CC=C(N)N=C1 SIURSMPFFMLOEH-HWKANZROSA-N 0.000 description 1
- NTNUDYROPUKXNA-UHFFFAOYSA-N methyl 2-(triphenyl-$l^{5}-phosphanylidene)acetate Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OC)C1=CC=CC=C1 NTNUDYROPUKXNA-UHFFFAOYSA-N 0.000 description 1
- SVWWNEYBEFASMP-UHFFFAOYSA-N methyl 2-aminopyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC(N)=C1 SVWWNEYBEFASMP-UHFFFAOYSA-N 0.000 description 1
- ZKIWDDKITFQWFT-UHFFFAOYSA-N methyl 3-(4-acetamido-3-methoxyphenyl)prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(NC(C)=O)C(OC)=C1 ZKIWDDKITFQWFT-UHFFFAOYSA-N 0.000 description 1
- UKOUQNDIFIQHKW-UHFFFAOYSA-N methyl 4-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-4-oxobutanoate Chemical compound COC(=O)CCC(=O)NC1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl UKOUQNDIFIQHKW-UHFFFAOYSA-N 0.000 description 1
- CDXJVGRHNJZXQO-UHFFFAOYSA-N methyl 4-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-4-oxobutanoate Chemical compound COC(=O)CCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl CDXJVGRHNJZXQO-UHFFFAOYSA-N 0.000 description 1
- BDNPHCCJNNAMFB-UHFFFAOYSA-N methyl 4-[3-(methylamino)-3-oxoprop-1-enyl]benzoate Chemical compound CNC(=O)C=CC1=CC=C(C(=O)OC)C=C1 BDNPHCCJNNAMFB-UHFFFAOYSA-N 0.000 description 1
- YWZVZZXRDZYICG-UHFFFAOYSA-N methyl 4-[[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]carbamoyloxy]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1OC(=O)NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl YWZVZZXRDZYICG-UHFFFAOYSA-N 0.000 description 1
- SRXOJMOGPYFZKC-UHFFFAOYSA-N methyl 4-chloro-4-oxobutanoate Chemical compound COC(=O)CCC(Cl)=O SRXOJMOGPYFZKC-UHFFFAOYSA-N 0.000 description 1
- URZXAMQJVQCEGJ-UHFFFAOYSA-N methyl 6-(hydroxymethyl)-3-methylquinoline-2-carboxylate Chemical compound C1=C(CO)C=C2C=C(C)C(C(=O)OC)=NC2=C1 URZXAMQJVQCEGJ-UHFFFAOYSA-N 0.000 description 1
- MAGNPXCCBOFDCC-UHFFFAOYSA-N methyl 6-formyl-3-methylquinoline-2-carboxylate Chemical compound C1=C(C=O)C=C2C=C(C)C(C(=O)OC)=NC2=C1 MAGNPXCCBOFDCC-UHFFFAOYSA-N 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- CAAULPUQFIIOTL-UHFFFAOYSA-N methyl dihydrogen phosphate Chemical compound COP(O)(O)=O CAAULPUQFIIOTL-UHFFFAOYSA-N 0.000 description 1
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 1
- ALHUXMDEZNLFTA-UHFFFAOYSA-N methyl-quinoxaline Natural products C1=CC=CC2=NC(C)=CN=C21 ALHUXMDEZNLFTA-UHFFFAOYSA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 1
- VJYXYXPGDZJZIN-UHFFFAOYSA-N n-(4-formyl-2-methoxyphenyl)acetamide Chemical compound COC1=CC(C=O)=CC=C1NC(C)=O VJYXYXPGDZJZIN-UHFFFAOYSA-N 0.000 description 1
- RAFCKVCCTRBHKG-UHFFFAOYSA-N n-(4-formyl-2-methylphenyl)acetamide Chemical compound CC(=O)NC1=CC=C(C=O)C=C1C RAFCKVCCTRBHKG-UHFFFAOYSA-N 0.000 description 1
- CVKTVLVHILBSMO-UHFFFAOYSA-N n-(4-formylpyridin-2-yl)acetamide Chemical compound CC(=O)NC1=CC(C=O)=CC=N1 CVKTVLVHILBSMO-UHFFFAOYSA-N 0.000 description 1
- VVDNQGICIUVXTD-UHFFFAOYSA-N n-(5-formylpyridin-2-yl)acetamide Chemical compound CC(=O)NC1=CC=C(C=O)C=N1 VVDNQGICIUVXTD-UHFFFAOYSA-N 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- DLROPFPRSLMEAO-UHFFFAOYSA-N n-[2,4-dichloro-3-[(2-methylquinolin-3-yl)oxymethyl]phenyl]-2-(1,3-dioxoisoindol-2-yl)acetamide Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(=O)NC1=C(Cl)C(COC2=CC3=CC=CC=C3N=C2C)=C(Cl)C=C1 DLROPFPRSLMEAO-UHFFFAOYSA-N 0.000 description 1
- LHJSYMKARAVYGC-UHFFFAOYSA-N n-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-2-(1,3-dioxoisoindol-2-yl)-n-ethylacetamide Chemical compound C1=C(C)N=C2C(OCC=3C(Cl)=CC=C(C=3Cl)N(C(=O)CN3C(C4=CC=CC=C4C3=O)=O)CC)=CC=CC2=C1 LHJSYMKARAVYGC-UHFFFAOYSA-N 0.000 description 1
- GVAMEQUBWHQXFH-UHFFFAOYSA-N n-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-2-(1,3-dioxoisoindol-2-yl)-n-methylacetamide Chemical compound C1=C(C)N=C2C(OCC=3C(Cl)=CC=C(C=3Cl)N(C(=O)CN3C(C4=CC=CC=C4C3=O)=O)C)=CC=CC2=C1 GVAMEQUBWHQXFH-UHFFFAOYSA-N 0.000 description 1
- XWDBJQQXVCWBNJ-UHFFFAOYSA-N n-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-n-methyl-2-[[2-[4-(4-nitrophenyl)piperazin-1-yl]acetyl]amino]acetamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)CN(CC1)CCN1C1=CC=C([N+]([O-])=O)C=C1 XWDBJQQXVCWBNJ-UHFFFAOYSA-N 0.000 description 1
- QWJIPCVEPUBJRW-VAWYXSNFSA-N n-[2,4-dichloro-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-n-methyl-3-[(e)-2-[4-(methylcarbamoyl)phenyl]ethenyl]benzamide Chemical compound C1=CC(C(=O)NC)=CC=C1\C=C\C1=CC=CC(C(=O)N(C)C=2C(=C(COC=3C4=NC(C)=CC=C4C=CC=3)C(Cl)=CC=2)Cl)=C1 QWJIPCVEPUBJRW-VAWYXSNFSA-N 0.000 description 1
- AUIICGWQUXTNML-UHFFFAOYSA-N n-[2,4-dimethoxy-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-2-(1,3-dioxoisoindol-2-yl)-n-methylacetamide Chemical compound C1=C(C)N=C2C(OCC3=C(OC)C(N(C)C(=O)CN4C(C5=CC=CC=C5C4=O)=O)=CC=C3OC)=CC=CC2=C1 AUIICGWQUXTNML-UHFFFAOYSA-N 0.000 description 1
- CCDWGZNYXQJNRN-UHFFFAOYSA-N n-[2,4-dimethyl-3-[(2-methylquinolin-8-yl)oxymethyl]phenyl]-2-(1,3-dioxoisoindol-2-yl)-n-methylacetamide Chemical compound C1=C(C)N=C2C(OCC=3C(C)=CC=C(C=3C)N(C(=O)CN3C(C4=CC=CC=C4C3=O)=O)C)=CC=CC2=C1 CCDWGZNYXQJNRN-UHFFFAOYSA-N 0.000 description 1
- PIMLVZIVYDNSQW-UHFFFAOYSA-N n-[2,4-dimethyl-3-[(3-methylquinoxalin-5-yl)oxymethyl]phenyl]-2-(1,3-dioxoisoindol-2-yl)-n-methylacetamide Chemical compound C1=C(C)N=C2C(OCC=3C(C)=CC=C(C=3C)N(C(=O)CN3C(C4=CC=CC=C4C3=O)=O)C)=CC=CC2=N1 PIMLVZIVYDNSQW-UHFFFAOYSA-N 0.000 description 1
- KNZUEGWNUJLQPU-UHFFFAOYSA-N n-[2-[2,4-dichloro-3-[[4-(dimethylamino)-2-methylquinolin-8-yl]oxymethyl]-n-methylanilino]-2-oxoethyl]-3-[4-[(2-methoxyacetyl)-(pyridin-3-ylmethyl)amino]phenyl]prop-2-enamide Chemical compound C=1C=C(C=CC(=O)NCC(=O)N(C)C=2C(=C(COC=3C4=NC(C)=CC(=C4C=CC=3)N(C)C)C(Cl)=CC=2)Cl)C=CC=1N(C(=O)COC)CC1=CC=CN=C1 KNZUEGWNUJLQPU-UHFFFAOYSA-N 0.000 description 1
- VYRIIGANOSSQIM-UHFFFAOYSA-N n-[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]-3-(3-methyl-4-nitrophenyl)prop-2-enamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)C=CC1=CC=C([N+]([O-])=O)C(C)=C1 VYRIIGANOSSQIM-UHFFFAOYSA-N 0.000 description 1
- YTEQNAMVCYTRRW-UHFFFAOYSA-N n-[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]-3-[4-(methanesulfonamido)-3-methylphenyl]prop-2-enamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)C=CC1=CC=C(NS(C)(=O)=O)C(C)=C1 YTEQNAMVCYTRRW-UHFFFAOYSA-N 0.000 description 1
- HSJRFFBTLICRKO-UHFFFAOYSA-N n-[2-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-n,2,4-trimethylanilino]-2-oxoethyl]-3-[4-(2-oxopyrrolidin-1-yl)phenyl]prop-2-enamide Chemical compound C=1C=C(C)C(COC=2C3=NC(C)=CC(C)=C3C=CC=2)=C(C)C=1N(C)C(=O)CNC(=O)C=CC(C=C1)=CC=C1N1CCCC1=O HSJRFFBTLICRKO-UHFFFAOYSA-N 0.000 description 1
- QCZWIQZNBOXCNO-UHFFFAOYSA-N n-[2-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-n,2,4-trimethylanilino]-2-oxoethyl]-3-[4-(propanoylamino)phenyl]prop-2-enamide Chemical compound C1=CC(NC(=O)CC)=CC=C1C=CC(=O)NCC(=O)N(C)C1=CC=C(C)C(COC=2C3=NC(C)=CC(C)=C3C=CC=2)=C1C QCZWIQZNBOXCNO-UHFFFAOYSA-N 0.000 description 1
- MDCUBWXXZYSLAA-UHFFFAOYSA-N n-[3-(chloromethyl)-2,4-dimethylphenyl]-2-(1,3-dioxoisoindol-2-yl)-n-methylacetamide Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(=O)N(C)C1=CC=C(C)C(CCl)=C1C MDCUBWXXZYSLAA-UHFFFAOYSA-N 0.000 description 1
- PQQLNWPTYGRLIM-UHFFFAOYSA-N n-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-2,4,6-trimethylphenyl]-2-(1,3-dioxoisoindol-2-yl)-n-methylacetamide Chemical compound C1=C(C)N=C2C(OCC=3C(C)=CC(C)=C(C=3C)N(C(=O)CN3C(C4=CC=CC=C4C3=O)=O)C)=CC=CC2=C1C PQQLNWPTYGRLIM-UHFFFAOYSA-N 0.000 description 1
- SBRAOXNMSBCFDX-UHFFFAOYSA-N n-[3-[(2,4-dimethylquinolin-8-yl)oxymethyl]-2,4-dimethylphenyl]-2-(1,3-dioxoisoindol-2-yl)-n-methylacetamide Chemical compound C1=C(C)N=C2C(OCC=3C(C)=CC=C(C=3C)N(C(=O)CN3C(C4=CC=CC=C4C3=O)=O)C)=CC=CC2=C1C SBRAOXNMSBCFDX-UHFFFAOYSA-N 0.000 description 1
- RKBVHDOUBHSVQE-UHFFFAOYSA-N n-[3-[[tert-butyl(diphenyl)silyl]oxymethyl]-2,4,6-trimethylphenyl]-2-(1,3-dioxoisoindol-2-yl)-n-methylacetamide Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(=O)N(C)C(C=1C)=C(C)C=C(C)C=1CO[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 RKBVHDOUBHSVQE-UHFFFAOYSA-N 0.000 description 1
- JWPWMSAYRPYHRI-UHFFFAOYSA-N n-[3-[[tert-butyl(diphenyl)silyl]oxymethyl]-2,4-dimethylphenyl]-2-(1,3-dioxoisoindol-2-yl)-n-ethylacetamide Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(=O)N(CC)C(C=1C)=CC=C(C)C=1CO[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 JWPWMSAYRPYHRI-UHFFFAOYSA-N 0.000 description 1
- IHYWZYMUBPXPFD-UHFFFAOYSA-N n-[4-[3-[[2-[2,4-dichloro-3-[[4-(dimethylamino)-2-methylquinolin-8-yl]oxymethyl]-n-methylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]phenyl]pyridine-4-carboxamide Chemical compound C1=CC=C2C(N(C)C)=CC(C)=NC2=C1OCC(C=1Cl)=C(Cl)C=CC=1N(C)C(=O)CNC(=O)C=CC(C=C1)=CC=C1NC(=O)C1=CC=NC=C1 IHYWZYMUBPXPFD-UHFFFAOYSA-N 0.000 description 1
- ZTKZGKIRPLCYGK-LFIBNONCSA-N n-[5-[(e)-3-[[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]pyridin-2-yl]-2-methylpyridine-3-carboxamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1NC(=O)C1=CC=CN=C1C ZTKZGKIRPLCYGK-LFIBNONCSA-N 0.000 description 1
- CNGAHALHQUQFSO-MHWRWJLKSA-N n-[5-[(e)-3-[[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]pyridin-2-yl]-6-methylpyridine-3-carboxamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1NC(=O)C1=CC=C(C)N=C1 CNGAHALHQUQFSO-MHWRWJLKSA-N 0.000 description 1
- UEDWZSNUIZVOHL-LFIBNONCSA-N n-[5-[(e)-3-[[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]pyridin-2-yl]pyridine-2-carboxamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1NC(=O)C1=CC=CC=N1 UEDWZSNUIZVOHL-LFIBNONCSA-N 0.000 description 1
- IHKDOUHAYWVQIA-XNTDXEJSSA-N n-[5-[(e)-3-[[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]pyridin-2-yl]pyridine-3-carboxamide Chemical compound C=1C=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C(Cl)C=1N(C)C(=O)CNC(=O)\C=C\C(C=N1)=CC=C1NC(=O)C1=CC=CN=C1 IHKDOUHAYWVQIA-XNTDXEJSSA-N 0.000 description 1
- PZOVCNKPBXMCDZ-FOWTUZBSSA-N n-methyl-5-[(e)-3-oxo-3-[[2-oxo-2-[n,2,4-trimethyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]ethyl]amino]prop-1-enyl]pyridine-2-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1\C=C\C(=O)NCC(=O)N(C)C1=CC=C(C)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1C PZOVCNKPBXMCDZ-FOWTUZBSSA-N 0.000 description 1
- MXANJYXGXRZELX-SDNWHVSQSA-N n-methyl-5-[(e)-3-oxo-3-[[2-oxo-2-[n,2,4-trimethyl-3-[(3-methylquinoxalin-5-yl)oxymethyl]anilino]ethyl]amino]prop-1-enyl]pyridine-2-carboxamide Chemical compound C1=NC(C(=O)NC)=CC=C1\C=C\C(=O)NCC(=O)N(C)C1=CC=C(C)C(COC=2C3=NC(C)=CN=C3C=CC=2)=C1C MXANJYXGXRZELX-SDNWHVSQSA-N 0.000 description 1
- RXOHFPCZGPKIRD-UHFFFAOYSA-N naphthalene-2,6-dicarboxylic acid Chemical compound C1=C(C(O)=O)C=CC2=CC(C(=O)O)=CC=C21 RXOHFPCZGPKIRD-UHFFFAOYSA-N 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- VMPITZXILSNTON-UHFFFAOYSA-N o-anisidine Chemical compound COC1=CC=CC=C1N VMPITZXILSNTON-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 229940039748 oxalate Drugs 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- BSCCSDNZEIHXOK-UHFFFAOYSA-N phenyl carbamate Chemical compound NC(=O)OC1=CC=CC=C1 BSCCSDNZEIHXOK-UHFFFAOYSA-N 0.000 description 1
- JRLUQGSODQQBFK-UHFFFAOYSA-N phenyl n-(1,3-benzothiazol-2-yl)carbamate Chemical compound N=1C2=CC=CC=C2SC=1NC(=O)OC1=CC=CC=C1 JRLUQGSODQQBFK-UHFFFAOYSA-N 0.000 description 1
- XVNKRRXASPPECQ-UHFFFAOYSA-N phenyl n-phenylcarbamate Chemical compound C=1C=CC=CC=1OC(=O)NC1=CC=CC=C1 XVNKRRXASPPECQ-UHFFFAOYSA-N 0.000 description 1
- ASYPRKQJWDKLCV-UHFFFAOYSA-N phenyl n-pyridin-4-ylcarbamate Chemical compound C=1C=CC=CC=1OC(=O)NC1=CC=NC=C1 ASYPRKQJWDKLCV-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical compound C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- REJGOFYVRVIODZ-UHFFFAOYSA-N phosphanium;chloride Chemical compound P.Cl REJGOFYVRVIODZ-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 1
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 125000004591 piperonyl group Chemical group C(C1=CC=2OCOC2C=C1)* 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- XFTQRUTUGRCSGO-UHFFFAOYSA-N pyrazin-2-amine Chemical compound NC1=CN=CC=N1 XFTQRUTUGRCSGO-UHFFFAOYSA-N 0.000 description 1
- NIPZZXUFJPQHNH-UHFFFAOYSA-N pyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=CC=N1 NIPZZXUFJPQHNH-UHFFFAOYSA-N 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- TXQWFIVRZNOPCK-UHFFFAOYSA-N pyridin-4-ylmethanamine Chemical compound NCC1=CC=NC=C1 TXQWFIVRZNOPCK-UHFFFAOYSA-N 0.000 description 1
- 125000005400 pyridylcarbonyl group Chemical group N1=C(C=CC=C1)C(=O)* 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000001525 receptor binding assay Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- XMVJITFPVVRMHC-UHFFFAOYSA-N roxarsone Chemical group OC1=CC=C([As](O)(O)=O)C=C1[N+]([O-])=O XMVJITFPVVRMHC-UHFFFAOYSA-N 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 description 1
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 1
- 229940039790 sodium oxalate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- UDYFLDICVHJSOY-UHFFFAOYSA-N sulfur trioxide-pyridine complex Substances O=S(=O)=O.C1=CC=NC=C1 UDYFLDICVHJSOY-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- GNNFDEWDBKIGOA-UHFFFAOYSA-N tert-butyl 2-[1,3-benzothiazol-2-yl-[(2-methylpropan-2-yl)oxycarbonyl]amino]acetate Chemical compound C1=CC=C2SC(N(C(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)=NC2=C1 GNNFDEWDBKIGOA-UHFFFAOYSA-N 0.000 description 1
- BNWCETAHAJSBFG-UHFFFAOYSA-N tert-butyl 2-bromoacetate Chemical compound CC(C)(C)OC(=O)CBr BNWCETAHAJSBFG-UHFFFAOYSA-N 0.000 description 1
- NBRKLOOSMBRFMH-UHFFFAOYSA-N tert-butyl chloride Chemical compound CC(C)(C)Cl NBRKLOOSMBRFMH-UHFFFAOYSA-N 0.000 description 1
- JWQBIRJVULZPNO-UHFFFAOYSA-N tert-butyl n-(1,3-benzothiazol-2-yl)carbamate Chemical compound C1=CC=C2SC(NC(=O)OC(C)(C)C)=NC2=C1 JWQBIRJVULZPNO-UHFFFAOYSA-N 0.000 description 1
- BQVFDPGMLGWKDF-UHFFFAOYSA-N tert-butyl n-[4-(methylcarbamoyl)phenyl]carbamate Chemical compound CNC(=O)C1=CC=C(NC(=O)OC(C)(C)C)C=C1 BQVFDPGMLGWKDF-UHFFFAOYSA-N 0.000 description 1
- YAPUSMZDXLZUQB-UHFFFAOYSA-N tert-butyl n-[[2,6-dichloro-3-[[2-(1,3-dioxoisoindol-2-yl)acetyl]-methylamino]phenyl]methyl]-n-(2-methylquinolin-8-yl)carbamate Chemical compound C1=C(C)N=C2C(N(C(=O)OC(C)(C)C)CC=3C(Cl)=CC=C(C=3Cl)N(C(=O)CN3C(C4=CC=CC=C4C3=O)=O)C)=CC=CC2=C1 YAPUSMZDXLZUQB-UHFFFAOYSA-N 0.000 description 1
- IMCNXDSDRNVVOD-UHFFFAOYSA-N tert-butyl-[(2,6-dichloro-3-nitrophenyl)methoxy]-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)OCC1=C(Cl)C=CC([N+]([O-])=O)=C1Cl IMCNXDSDRNVVOD-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 239000003451 thiazide diuretic agent Substances 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 125000005425 toluyl group Chemical group 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- QIWRFOJWQSSRJZ-UHFFFAOYSA-N tributyl(ethenyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C=C QIWRFOJWQSSRJZ-UHFFFAOYSA-N 0.000 description 1
- CSOFCRNQJRIIGC-UHFFFAOYSA-N tributyl-[2-[[2-[2,4-dichloro-n-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]amino]-2-oxoethyl]phosphanium;bromide Chemical compound [Br-].CCCC[P+](CCCC)(CCCC)CC(=O)NCC(=O)N(C)C1=CC=C(Cl)C(COC=2C3=NC(C)=CC=C3C=CC=2)=C1Cl CSOFCRNQJRIIGC-UHFFFAOYSA-N 0.000 description 1
- ZMCBYSBVJIMENC-UHFFFAOYSA-N tricaine Chemical compound CCOC(=O)C1=CC=CC(N)=C1 ZMCBYSBVJIMENC-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000018464 vernal keratoconjunctivitis Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式 [式中、Zは式 (式中、X1はNまたはC−R1、 X2はNまたはC−R9、 X3はNまたはC−R2、 R1は低級アルキル基、 R2は水素;低級アルキル基;ハロゲン;アリール基;ヒドロキシ(低級 )アルキル基;低級アルコキシ(低級)アルキル基;カルボキシ基;エステル化 されたカルボキシ基;低級アルキルで任意に置換されていてもよいカルバモイル 基;シクロ(低級)アルコキシ基;低級アルコキシ、低級アルキルアミノ、ヒド ロキシ、カルボキシ、エステル化されたカルボキシおよび、低級アルキルで任意 に置換されていてもよいカルバモイルよりなる群から選択された置換基で任意に 置換されていてもよい低級アルコキシ基;ハロ(低級)アルコキシ基;低級アル コキシ、低級アルキルアミノおよびエステル化されたカルボキシよりなる群から 選択された置換基で任意に置換されていてもよい低級アルキルアミノ基;低級ア ルケニルアミノ基;または低級アルキルで任意に置換されていてもよいN−含有 複素環−N−イル基、 R9は水素または低級アルキル基、 をそれぞれ意味する) で表される基、 R3は水素、低級アルキル基、低級アルコキシ基またはハロゲン、 R4は低級アルキル基、低級アルコキシ基またはハロゲン、 R5は水素;ニトロ基;アミノ、アシルアミノおよび低級アルコキシよりなる 群から選択された置換基で任意に置換されていてもよい低級アルコキシ基;アシ ル(低級)アルキルおよびオキソで置換されたピペラジニル基;または式 (式中、R6は水素または低級アルキル基、 R7は水素;アリールオキシカルボニル基;アシル−アル(低級)アルケ ニル、アシル−アル(低級)アルコキシ、アシル−アリールオキシ(低級)アル キルおよびアシル−アル(低級)アルキルよりなる群から選択された置換基で任 意に置換されていてもよいアロイル基;アシル−アル(低級)アルケニルで任意 に置換されていてもよい複素環カルボニル基;アシル(低級)アルカノイル基; ヒドロキシ(低級)アルカノイル基;アシルオキシ(低級)アルカノイル基;ア シル(低級)アルキルで任意に置換されていてもよいカルバモイル基;または式 −(AA)−CO−Q−R8 または −(AA)−R10、 (式中、R8はアリールチオ基、アリールオキシ基またはアリールアミノ基 であって、その各々はアシル、複素環(低級)アルキル、複素環(低級)アルケ ニル、ニトロ、アミノおよびアシルアミノよりなる群から選択された置換基で任 意に置換されていてもよい;複素環チオ基または複素環アミノ基で あって、その各々はアシル、アシルアミノ、アミノおよび低級アルコキシよりな る群から選択された置換基で任意に置換されていてもよい;ハロゲン;トリ(低 級)アルキルホスホニオ基;低級アルキル、低級アルコキシ、アシル(低級)ア ルケニル、複素環(低級)アルケニル、ニトロ、アシル、アシル(低級)アルコ キシ、グアニジノ、アミノ、アシルアミノ、N−アシル−N−[複素環(低級) アルキル]アミノおよび、オキソで置換されたN−含有複素環−N−イル基より なる群から選択された置換基で置換されたアリール基;またはオキソ、低級アル キル、低級アルコキシ、ニトロ−アリール、アシル、アシルアミノ、アミノ、N −アシル−N−(低級)アルキルアミノ、低級アルキルアミノ、ハロゲン、複素 環(低級)アルキル、複素環(低級)アルケニルおよび、オキソで置換されたN −含有複素環−N−イル基よりなる群から選択された置換基で任意に置換されて いてもよい複素環基、 R10は水素またはアシルビフェニル基、 (AA)はアミノ酸残基、 Qは低級アルキレン基、低級アルケニレン基または単結合、 をそれぞれ意味する) で表される基をそれぞれ意味する) で表される基、 Aは低級アルキレン基、 YはOまたはN−R11(式中、R11は水素またはN−保護基) をそれぞれ意味する] で表される化合物および医薬として許容されるその塩。 2.Zが式 で表される基、 R5が式 (式中、R6は水素または低級アルキル基、 R7は水素、または式 −(AA)−CO−Q−R8 または −(AA)−R10 で表される基、をそれぞれ意味する) で表される基である請求の範囲第1項に記載の化合物。 3.R8がフェニルチオ基、フェニルオキシ基またはフェニルアミノ基であっ て、その各々は低級アルコキシカルボニル、低級アルキルカルバモイル、低級ア ルキルスルホニルカルバモイル、トリルスルホニルカルバモイル、ピリジルカル バモイル、ピリジル(低級)アルキルカルバモイル、ピリジル(低級)アルキル 、ピリジル(低級)アルケニル、ニトロ、アミノ、低級アルカノイルアミノおよ びピリジルカルボニルアミノよりなる群から選択された置換基で任意に置換され ていてもよい;複素環チオ基または複素環アミノ基であって、その各々はカルボ キシ、低級アルコキシカルボニル、低級アルキルカルバモイル、低級アルカノイ ルアミノ、アミノおよび低級アルコキシよりなる群から選択された置換基で任意 に置換されていてもよい;ハロゲン;トリ(低級)アルキルホスホニオ基;フェ ニル基またはナフチル基であって、その各々は低級アルキル、低級アルコキシ、 ニトロ、カルボキシ、低級アルコキシカルボニル、低級アルキルカルバモイル、 低級アルキルアミノ(低級)アルキルカルバモイル、N−[低級アルキルアミノ (低級)アルキル]−N−(低級アルキル)カルバモイル、ピリジルカルバモイ ル、ピリジル(低級)アルキルカルバモイルまたはそのオキシド、低級アルコキ シカルボニル(低級)アルケニル、低級アルキルカルバモイル(低級)アルケニ ル、ピリジル(低級)アルケニル、カルボキシ(低級)アルコキシ、低級アルコ キシカルボニル(低級)アルコキシ、低級アルキルカルバモイル(低級)アルコ キシ、グアニジノ、アミノ、低級アルカノイルアミノ、ハロ(低級)アルカノイ ルアミノ、低級アルキルスルホニルアミノ、ピリジルカルボニルアミノ、低級ア ルキルウレイド、N−[低級アルコキシ(低級)アルカノイル]−N−[ピリジ ル(低級)アルキル]アミノ、2−オキソピロリジン−1−イルおよび2−オキ ソ−1,2−ジヒドロピリジン−1−イルよりなる群から選択された置換基で置 換されている;またはピリジル基、キノリル基、インドリル基、テトラヒドロキ ノリル基またはピペラジニル基であって、その各々はオキソ、低級アルキル、低 級アルコキシ、ニトロフェニル、カルボキシ、低級アルコキシカルボニル、低級 アルカノイル、低級アルキルカルバモイル、ピリジルカルバモイル、ピラジニル カルバモイル、イソキノリルカルバモイル、チアゾリルカルバモイル、低級アル キルオキサゾリルカルバモイル、低級アルキルピラゾリルカルバモイル、低級ア ルコキシピリジルカルバモイル、ピリジル(低級)アルキルカルバモイル、アミ ノ、低級アルカノイルアミノ、ピリジルカルボニルアミノ、ピラジニルカルボニ ルアミノ、低級アルキルピリジルカルボニルアミノ、低級アルコキシピリジルカ ルボニルアミノ、低級アルキルチオピリジルカルボニルアミノ、ピリジル(低級 )アルカノイルアミノ、低級アルキルピリジル(低級)アルカノイルアミノ、低 級アルキルスルホニルアミノ、低級アルキルウレイド、N−(低級アルカノイル )−N−(低級)アルキルアミノ、低級アルキルアミノ、ハロゲン、ピリジル( 低級)アルキル、ピリジル(低級)アルケニルおよび2−オキソピロリジン−1 −イルよりなる群から選択された置換基で任意に置換されていてもよい、 R10が低級アルキルカルバモイルビフェニル基、 である請求の範囲第2項に記載の化合物。 4.Zが式 (式中、R2はアリール基;ヒドロキシ(低級)アルキル基;低級アルコキシ( 低級)アルキル基;カルボキシ基;エステル化されたカルボキシ基;低級アルキ ルで任意に置換されていてもよいカルバモイル基;シクロ(低級)アルコキシ基 ;カルボキシ、エステル化されたカルボキシおよび、低級アルキルで任意に置換 されていてもよいカルバモイルよりなる群から選択された置換基で置換された低 級アルコキシ基;ハロ(低級)アルコキシ基;低級アルコキシ、低級アルキルア ミノおよびエステル化されたカルボキシよりなる群から選択された置換基で置換 された低級アルキルアミノ基;低級アルケニルアミノ基;または低級アルキルで 任意に置換されていてもよいN−含有複素環−N−イル基を意味する) で表される基である請求の範囲第1、2または3項に記載の化合物。 5.R3が水素、低級アルキル基または低級アルコキシ基、 R4が低級アルキル基または低級アルコキシ基、 である請求の範囲第1、2または3項に記載の化合物。 6.式 [式中、Zは式 (式中、X1はNまたはC−R1、 X2はNまたはC−R9、 X3はNまたはC−R2、 R1は低級アルキル基、 R2は水素;低級アルキル基;ハロゲン;アリール基;ヒドロキシ(低級 )アルキル基;低級アルコキシ(低級)アルキル基;カルボキシ基;エステル化 されたカルボキシ基;低級アルキルで任意に置換されていてもよいカルバモイル 基;シクロ(低級)アルコキシ基;低級アルコキシ、低級アルキルアミノ、ヒド ロキシ、カルボキシ、エステル化されたカルボキシおよび、低級アルキルで任意 に置換されていてもよいカルバモイルよりなる群から選択された置換基で任意に 置換されていてもよい低級アルコキシ基;ハロ(低級)アルコキシ基;低級アル コキシ、低級アルキルアミノおよびエステル化されたカルボキシよりなる群から 選択された置換基で任意に置換されていてもよい低級アルキルアミノ基;低級ア ルケニルアミノ基;または低級アルキルで任意に置換されていてもよいN−含有 複素環−N−イル基、 R9は水素または低級アルキル基、 をそれぞれ意味する) で表される基、 R3は水素、低級アルキル基、低級アルコキシ基またはハロゲン、 R4は低級アルキル基、低級アルコキシ基またはハロゲン、 R5は水素;ニトロ基;アミノ、アシルアミノおよび低級アルコキシよりなる 群から選択された置換基で任意に置換されていてもよい低級アルコキシ基;アシ ル(低級)アルキルおよびオキソで置換されたピペラジニル基;または式 (式中、R6は水素または低級アルキル基、 R7は水素;アリールオキシカルボニル基;アシル−アル(低級)アルケ ニル、アシル−アル(低級)アルコキシ、アシル−アリールオキシ(低級)アル キルおよびアシル−アル(低級)アルキルよりなる群から選択された置換基で任 意に置換されていてもよいアロイル基;アシル−アル(低級)アル ケニルで任意に置換されていてもよい複素環カルボニル基;アシル(低級)アル カノイル基;ヒドロキシ(低級)アルカノイル基;アシルオキシ(低級)アルカ ノイル基;アシル(低級)アルキルで任意に置換されていてもよいカルバモイル 基;または式 −(AA)−CO−Q−R8 または −(AA)−R10、 (式中、R8はアリールチオ基、アリールオキシ基またはアリールアミノ基 であって、その各々はアシル、複素環(低級)アルキル、複素環(低級)アルケ ニル、ニトロ、アミノおよびアシルアミノよりなる群から選択された置換基で任 意に置換されていてもよい;複素環チオ基または複素環アミノ基であって、その 各々はアシル、アシルアミノ、アミノおよび低級アルコキシよりなる群から選択 された置換基で任意に置換されていてもよい;ハロゲン;トリ(低級)アルキル ホスホニオ基;低級アルキル、低級アルコキシ、アシル(低級)アルケニル、複 素環(低級)アルケニル、ニトロ、アシル、アシル(低級)アルコキシ、グアニ ジノ、アミノ、アシルアミノ、N−アシル−N−[複素環(低級)アルキル]ア ミノおよび、オキソで置換されたN−含有複素環−N−イル基よりなる群から選 択された置換基で置換されたアリール基;またはオキソ、低級アルキル、低級ア ルコキシ、ニトロ−アリール、アシル、アシルアミノ、アミノ、N−アシル−N −(低級)アルキルアミノ、低級アルキルアミノ、ハロゲン、複素環(低級)ア ルキル、複素環(低級)アルケニルおよび、オキソで置換されたN−含有複素環 −N−イル基よりなる群から選択された置換基で任意に置換されていてもよい複 素環基、 R10は水素またはアシルビフェニル基、 (AA)はアミノ酸残基、 Qは低級アルキレン基、低級アルケニレン基または単結合、 をそれぞれ意味する) で表される基をそれぞれ意味する) で表される基、 Aは低級アルキレン基、 YはOまたはN−R11(式中、R11は水素またはN−保護基) をそれぞれ意味する] で表される化合物またはその塩の製造法であって、 a)式 Z−YH (式中、YおよびZは、それぞれ前記定義の通りである) で表される化合物またはその塩を、式 (式中、Xは脱離基、 R3、R4、R5およびAはそれぞれ前記定義の通りである) で表される化合物またはその塩と反応させて、式 (式中、R3、R4、R5、A、YおよびZはそれぞれ前記定義の通りである) で表される化合物またはその塩を得るか、または b)式 (式中、R3、R4、R6、A、Y、Zおよび(AA)はそれぞれ前記定義の通り である) で表される化合物またはその塩を、式 R8−Q−COOH (式中、R8およびQはそれぞれ前記定義の通りである) で表される化合物またはカルボキシ基におけるその反応性誘導体またはそれらの 塩と反応させて、式 (式中、R3、R4、R6、R8、A、Y、Z、(AA)およびQはそれぞれ前記定 義の通りである) で表される化合物またはその塩を得るか、または c)式 (式中、Qaは低級アルキレン基、 R3、R4、R6、A、Y、Z、(AA)およびXはそれぞれ前記定義の通りで ある) で表される化合物またはその塩を、式 置換基で任意に置換されていてもよいアリールチオ基;またはアシル、アシルア ミノ、アミノおよび低級アルコキシよりなる群から選択された置換基で任意に置 換されていてもよい複素環チオ基を意味する) で表される化合物またはその塩と反応させて、式 れ前記定義の通りである) で表される化合物またはその塩を得ることを特徴とする前記製造法。 7.請求の範囲第1項に記載の化合物を有効成分として、医薬として許容され 実質的に無毒の担体または賦形剤と共に含有する医薬組成物。 8.薬剤としての使用のための請求の範囲第1項に記載の化合物。 9.請求の範囲第1項に記載の化合物を人類または動物に投与することからな る、ブラジキニンまたはその類縁体が誘発する疾患の予防および/または治療方 法。 10.ブラジキニンまたはその類縁体が誘発する疾患の予防および/または治療 のための薬剤を製造するための請求の範囲第1項に記載の化合物の使用。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9421684.3 | 1994-10-27 | ||
| GB9421684A GB9421684D0 (en) | 1994-10-27 | 1994-10-27 | New heterocyclic compounds |
| GBGB9512339.4A GB9512339D0 (en) | 1995-06-16 | 1995-06-16 | New heterocyclic compounds |
| GB9512339.4 | 1995-06-16 | ||
| PCT/JP1995/002192 WO1996013485A1 (en) | 1994-10-27 | 1995-10-25 | Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10507764A true JPH10507764A (ja) | 1998-07-28 |
| JP3697486B2 JP3697486B2 (ja) | 2005-09-21 |
Family
ID=26305878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51416696A Expired - Lifetime JP3697486B2 (ja) | 1994-10-27 | 1995-10-25 | ブラジキニン拮抗剤としての、ピリドピリミドン類、キノリン類および縮合n−複素環類 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5994368A (ja) |
| EP (1) | EP0807105B1 (ja) |
| JP (1) | JP3697486B2 (ja) |
| KR (1) | KR970707098A (ja) |
| CN (1) | CN1168667A (ja) |
| AT (1) | ATE269310T1 (ja) |
| AU (1) | AU705883B2 (ja) |
| CA (1) | CA2203659A1 (ja) |
| DE (1) | DE69533174T2 (ja) |
| ES (1) | ES2218554T3 (ja) |
| WO (1) | WO1996013485A1 (ja) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010510242A (ja) * | 2006-11-16 | 2010-04-02 | アラーガン、インコーポレイテッド | キナーゼ阻害剤としてのスルホキシミン |
| JP2013523747A (ja) * | 2010-03-29 | 2013-06-17 | タイペイ・メディカル・ユニバーシティ | インドリルヒドロキサメート化合物又はインドリニルヒドロキサメート化合物 |
| JP2022533487A (ja) * | 2019-05-23 | 2022-07-22 | ファーヴァリス ゲーエムベーハー | 皮膚疾患を処置するためのブラジキニン(bk)b2受容体アンタゴニストとしての(r)-3-(クロロ-5-フルオロ-2-((4-(1h-ピラゾール-1-イル)-2-メチルキノリン-8-イルオキシ)メチル)フェニル)モルホリン誘導体および関連化合物 |
| JP2022534389A (ja) * | 2019-05-23 | 2022-07-29 | ファーヴァリス ゲーエムベーハー | 皮膚疾患を処置するためのブラジキニン(bk)b2受容体アンタゴニストとしての1-((s)-1-(3-クロロ-5-フルオロ-2-((4-(1h-ピラゾール-1-イル)-2-メチルキノリン-8-イルオキシ)メチル)フェニル)エチル)-イミダゾリジン-2,4-ジオン誘導体および関連化合物 |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9519077D0 (en) | 1995-09-18 | 1995-11-15 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
| DE19609827A1 (de) * | 1996-03-13 | 1997-09-18 | Hoechst Ag | Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten |
| DE19610784A1 (de) * | 1996-03-19 | 1997-09-25 | Hoechst Ag | Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung |
| AUPN952696A0 (en) * | 1996-04-29 | 1996-05-23 | Fujisawa Pharmaceutical Co., Ltd. | New heterocyclic compounds |
| DE19620508A1 (de) * | 1996-05-22 | 1997-11-27 | Hoechst Ag | Schwefelenthaltende heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung |
| FR2751650B1 (fr) * | 1996-07-24 | 1998-10-09 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
| DE59712118D1 (de) * | 1996-10-14 | 2005-01-20 | Aventis Pharma Gmbh | Verwendung von nicht-peptidischen Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimerischen Krankheit |
| DE19712960A1 (de) | 1997-03-27 | 1998-10-01 | Hoechst Ag | Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten |
| TW521072B (en) * | 1997-06-02 | 2003-02-21 | Meiji Seika Kaisha | 4-quinolinol derivatives and fungicides containing the same as an active ingredient used for agriculture and horticulture |
| NZ507760A (en) | 1998-03-26 | 2002-10-25 | Japan Tobacco Inc | Amide derivatives and nociceptin antagonists |
| WO2000039103A1 (en) | 1998-12-23 | 2000-07-06 | Aventis Pharma Limited | Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines |
| WO2000045635A1 (en) * | 1999-02-08 | 2000-08-10 | Lion Bioscience Ag | Thiazole derivatives and combinatorial libraries thereof |
| FR2790260B1 (fr) | 1999-02-26 | 2001-05-04 | Fournier Ind & Sante | Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique |
| US6455734B1 (en) * | 2000-08-09 | 2002-09-24 | Magnesium Diagnostics, Inc. | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| US6417366B2 (en) * | 1999-06-24 | 2002-07-09 | Abbott Laboratories | Preparation of quinoline-substituted carbonate and carbamate derivatives |
| US6699486B1 (en) | 1999-11-18 | 2004-03-02 | Bolla Corporation | Treatment or prevention of photoaging and skin cancer |
| US7105172B1 (en) | 1999-11-18 | 2006-09-12 | Bolla John D | Treatment of rosacea |
| US6511980B2 (en) * | 2000-05-05 | 2003-01-28 | Ortho Mcneil Pharmaceutical, Inc. | Substituted diamine derivatives useful as motilin antagonists |
| KR20030027094A (ko) | 2000-08-29 | 2003-04-03 | 야마노우치세이야쿠 가부시키가이샤 | 신규 에스테르 또는 아미드 유도체 |
| EP1914236A1 (en) | 2002-04-10 | 2008-04-23 | Ortho-McNeil Pharmaceutical, Inc. | Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| US7507735B2 (en) | 2004-06-17 | 2009-03-24 | Cytokinetics, Inc. | Compounds, compositions and methods |
| TW200808321A (en) | 2005-12-15 | 2008-02-16 | Cytokinetics Inc | Certain chemical entities, compositions and methods |
| US7825120B2 (en) * | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
| WO2007078839A2 (en) * | 2005-12-19 | 2007-07-12 | Cytokinetics, Inc. | Compounds, compositions and methods |
| US20070192858A1 (en) * | 2006-02-16 | 2007-08-16 | Infoexpress, Inc. | Peer based network access control |
| TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽b2受體調節劑 |
| FR2930247B1 (fr) * | 2008-04-21 | 2012-12-07 | Commissariat Energie Atomique | Sels d'onium et leur utilisation pour la detection et le dosage des metaux. |
| US8883857B2 (en) | 2012-12-07 | 2014-11-11 | Baylor College Of Medicine | Small molecule xanthine oxidase inhibitors and methods of use |
| AR099120A1 (es) | 2014-01-20 | 2016-06-29 | Bayer Cropscience Ag | Derivados de quinolina como insecticidas y acaricidas |
| MY202326A (en) | 2017-09-14 | 2024-04-24 | Daiichi Sankyo Co Ltd | Compound having cyclic structure |
| SMT202200154T1 (it) | 2017-11-24 | 2022-05-12 | Pharvaris Netherlands B V | Nuovi antagonisti del recettore della bradichinina b2 |
| KR20240039185A (ko) | 2021-08-05 | 2024-03-26 | 파르바리스 게엠베하 | 브래디키닌 b2-수용체 길항제의 경구 투여용 지질 기반 조성물 |
| TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽b2受體拮抗劑之固態延長釋放組成物 |
| WO2023180577A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Therapeutic uses of bradykinin b2-receptor antagonists |
| HRP20260166T1 (hr) | 2022-03-25 | 2026-03-27 | Pharvaris Gmbh | Čvrsti sastav koji sadrži solubilizirane antagoniste bradikinin b2 receptora |
| CN115616227B (zh) * | 2022-11-18 | 2023-05-16 | 四川大学华西医院 | 吲哚-3-丙烯酰甘氨酸检测试剂的用途、诊断或辅助诊断慢性阻塞性肺病的试剂盒及系统 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3617183A1 (de) * | 1985-11-16 | 1987-05-27 | Bayer Ag | Substituierte benzylether |
| DE3632329A1 (de) * | 1986-09-24 | 1988-03-31 | Bayer Ag | Substituierte phenylsulfonamide |
| US5212182A (en) * | 1990-10-03 | 1993-05-18 | American Home Products Corpooration | Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics |
| US5480883A (en) * | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| FR2692581B1 (fr) * | 1992-06-18 | 1994-08-19 | Adir | Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| US5574042A (en) * | 1992-11-02 | 1996-11-12 | Fujisawa Pharmaceutical Co., Ltd | Imidazo [1,2-a] pyridines and their pharmaceutical use |
| AU686115B2 (en) * | 1992-11-02 | 1998-02-05 | Fujisawa Pharmaceutical Co., Ltd. | Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation |
| AU680870B2 (en) * | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
-
1995
- 1995-10-25 CN CN95196602A patent/CN1168667A/zh active Pending
- 1995-10-25 KR KR1019970702615A patent/KR970707098A/ko not_active Ceased
- 1995-10-25 ES ES95935563T patent/ES2218554T3/es not_active Expired - Lifetime
- 1995-10-25 AT AT95935563T patent/ATE269310T1/de not_active IP Right Cessation
- 1995-10-25 WO PCT/JP1995/002192 patent/WO1996013485A1/en not_active Ceased
- 1995-10-25 JP JP51416696A patent/JP3697486B2/ja not_active Expired - Lifetime
- 1995-10-25 DE DE1995633174 patent/DE69533174T2/de not_active Expired - Fee Related
- 1995-10-25 EP EP95935563A patent/EP0807105B1/en not_active Expired - Lifetime
- 1995-10-25 AU AU37536/95A patent/AU705883B2/en not_active Ceased
- 1995-10-25 CA CA002203659A patent/CA2203659A1/en not_active Abandoned
-
1997
- 1997-04-25 US US08/809,416 patent/US5994368A/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010510242A (ja) * | 2006-11-16 | 2010-04-02 | アラーガン、インコーポレイテッド | キナーゼ阻害剤としてのスルホキシミン |
| JP2013523747A (ja) * | 2010-03-29 | 2013-06-17 | タイペイ・メディカル・ユニバーシティ | インドリルヒドロキサメート化合物又はインドリニルヒドロキサメート化合物 |
| JP2022533487A (ja) * | 2019-05-23 | 2022-07-22 | ファーヴァリス ゲーエムベーハー | 皮膚疾患を処置するためのブラジキニン(bk)b2受容体アンタゴニストとしての(r)-3-(クロロ-5-フルオロ-2-((4-(1h-ピラゾール-1-イル)-2-メチルキノリン-8-イルオキシ)メチル)フェニル)モルホリン誘導体および関連化合物 |
| JP2022534389A (ja) * | 2019-05-23 | 2022-07-29 | ファーヴァリス ゲーエムベーハー | 皮膚疾患を処置するためのブラジキニン(bk)b2受容体アンタゴニストとしての1-((s)-1-(3-クロロ-5-フルオロ-2-((4-(1h-ピラゾール-1-イル)-2-メチルキノリン-8-イルオキシ)メチル)フェニル)エチル)-イミダゾリジン-2,4-ジオン誘導体および関連化合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| US5994368A (en) | 1999-11-30 |
| AU3753695A (en) | 1996-05-23 |
| ES2218554T3 (es) | 2004-11-16 |
| CA2203659A1 (en) | 1996-05-09 |
| ATE269310T1 (de) | 2004-07-15 |
| KR970707098A (ko) | 1997-12-01 |
| DE69533174T2 (de) | 2004-11-18 |
| EP0807105A1 (en) | 1997-11-19 |
| WO1996013485A1 (en) | 1996-05-09 |
| JP3697486B2 (ja) | 2005-09-21 |
| DE69533174D1 (de) | 2004-07-22 |
| EP0807105B1 (en) | 2004-06-16 |
| AU705883B2 (en) | 1999-06-03 |
| CN1168667A (zh) | 1997-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5994368A (en) | Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin antagonists | |
| EP0596406B1 (en) | Imidazo (1,2-a) Pyridines as bradykinin antagonists | |
| RU2135478C1 (ru) | Гетероциклические соединения, способ их получения, фармацевтическая композиция и способ лечения | |
| EP0876345B1 (en) | Heterocyclic compounds as h+-atpases | |
| US5574042A (en) | Imidazo [1,2-a] pyridines and their pharmaceutical use | |
| JP4092732B2 (ja) | ブラジキニン作動薬としてのキノリンおよびベンズイミダゾール誘導体 | |
| JP2000515848A (ja) | ブラジキニン拮抗薬としての複素環式化合物 | |
| US6194396B1 (en) | Benzimidazole compounds as bradykinin antagonists | |
| US6083959A (en) | Quinoline derivatives, processes for their preparation and their use as medicaments | |
| HK1004482A (en) | Heterocyclic compounds as bradykinin antagonists | |
| JPWO1996004251A1 (ja) | 複素環化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040928 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041124 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050208 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050314 |
|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7421 Effective date: 20050314 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050524 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050603 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20050520 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080715 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090715 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090715 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100715 Year of fee payment: 5 |